Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3026285	s-antitry	g/l (g/l)	5979	6474	0.03%
3026285	s-antitry	— (—)	597	630	100.00%	Distribution not available
3026285	s-antitry	g/l_______ (g/l)	73	74	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD medications

1975

3878

2.79

319.98

1.1

1.53

1.48

g/l

3.82

1849

3526

Hepatocellular carcinoma, including Hilmo

233

120

23.88

308.88

1.4

1.1

1.63

1.58

g/l

0.51

224

106

Inflammatory bowel disease treatment related agents

1993

4149

2.71

308.72

1.1

1.52

1.49

g/l

1.61

1866

3778

GASTRO-related operations

1311

1398

4.79

307.65

1.1

1.51

1.40

g/l

13.32

1207

1279

Abnormal findings on examination of blood, without diagnosis

1227

2579

4.47

307.65

1.1

1.50

1.54

g/l

2.58

1153

2334

Diseases of liver

2725

1380

23.12

307.65

1.1

1.55

1.47

g/l

9.04

2480

1265

Nonalcoholic fatty liver disease

980

544

22.73

307.65

1.1

1.43

1.50

g/l

3.80

900

496

Cirrhosis of liver, NAS

655

232

39.82

307.65

1.2

1.1

1.65

1.52

g/l

4.95

609

213

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

329

276

13.33

307.65

1.3

1.1

1.66

1.54

g/l

3.30

311

241

Any gastric operation

1311

1398

4.79

307.65

1.1

1.51

1.40

g/l

13.32

1207

1279

Fibrosis and cirrhosis of liver

830

241

45.84

307.65

1.2

1.1

1.63

1.51

g/l

4.08

767

223

Chronic hepatitis, not elsewhere classified

279

102

34.03

307.65

1.2

1.1

1.55

1.46

g/l

1.90

255

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

292

203

16.52

307.65

1.3

1.1

1.66

1.55

g/l

2.33

277

179

Other diseases of liver

1489

683

26.07

307.65

1.1

1.47

g/l

0.08

1344

636

Alcoholic liver disease

645

341

22.02

307.65

1.2

1.1

1.69

1.51

g/l

8.93

574

315

Oesophageal varices

412

196

27.70

307.65

1.2

1.1

1.61

1.51

g/l

2.48

384

181

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1210

668

21.97

307.65

1.2

1.1

1.65

1.50

g/l

14.91

1109

610

Ascites

438

324

15.41

307.65

1.2

1.1

1.72

1.51

g/l

10.93

407

299

Abnormal serum enzyme levels

931

1701

5.57

307.65

1.1

1.48

1.55

g/l

5.48

876

1543

ILD medications: prednisolone, methylprednisolone, prednisone

1876

3806

2.78

306.08

1.1

1.52

1.48

g/l

3.09

1751

3459

Hepatic failure, not elsewhere classified

228

114

23.40

304.31

1.2

1.1

1.66

1.45

g/l

5.81

210

104

ILD medications: immunosuppressive drugs

1249

3632

3.18

294.32

1.2

1.1

1.53

1.48

g/l

4.08

1187

3306

First line medication for Crohn's disease

1885

3772

2.73

293.89

1.1

1.52

1.48

g/l

3.50

1765

3427

Primary Sclerosing Cholangitis, IBD and UDCA required

214

104

26.78

292.66

1.2

1.1

1.56

1.41

g/l

4.32

201

Other inflammatory liver diseases

282

227

13.72

292.10

1.1

1.61

1.48

g/l

4.09

264

207

Cholangitis (primary sclerosing, PSC)

300

281

11.86

282.25

1.2

1.1

1.62

1.48

g/l

4.66

284

250

Asthma, excluding more controls

1321

2110

3.27

273.20

1.1

1.46

1.48

g/l

1.20

1230

1934

Primary biliary cholangitis, wide definition

198

25.77

268.94

1.2

1.1

1.58

1.49

g/l

1.29

182

Oral corticosteroids

1786

4034

2.64

267.89

1.1

1.52

1.50

g/l

1.58

1660

3672

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1252

3703

3.01

264.90

1.1

1.51

1.53

g/l

1.42

1148

3378

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

254

209

13.59

260.14

1.3

1.1

1.67

1.54

g/l

2.98

243

184

Asthma (only as main-diagnosis), excluding more controls

1224

2110

3.27

259.43

1.1

1.44

1.48

g/l

2.60

1136

1934

Asthma

1343

2263

3.11

257.92

1.1

1.46

1.50

g/l

2.14

1250

2078

Abnormal results of function studies

362

490

8.02

255.32

1.1

1.46

1.50

g/l

0.80

311

446

Malignant neoplasm of liver and intrahepatic bile ducts

204

118

20.31

255.01

1.3

1.1

1.65

1.58

g/l

0.93

195

107

Gastrointestinal diseases

830

955

4.42

252.16

1.1

1.49

1.42

g/l

3.78

752

894

Asthma (only as main-diagnosis)

1238

2263

3.11

244.47

1.1

1.44

1.50

g/l

3.86

1149

2078

Autoimmune hepatitis, wide definition

242

209

13.05

240.76

1.1

1.59

1.49

g/l

2.57

227

188

COPD

833

1903

3.65

234.94

1.1

1.55

1.57

g/l

0.49

766

1724

Disorders of gallbladder, biliary tract and pancreas

1653

4118

2.54

234.05

1.1

1.53

1.51

g/l

1.53

1532

3765

Chronic lower respiratory diseases

1946

4334

2.40

233.58

1.1

1.48

1.51

g/l

2.35

1802

3963

Hepatocellular carcinoma

169

24.15

225.98

1.3

1.0

1.63

1.56

g/l

0.67

163

Emphysema

280

323

9.38

225.28

1.1

1.50

1.56

g/l

1.02

264

295

Alcohol use disorder, Swedish definition

1053

3310

2.96

218.65

1.1

1.64

1.49

g/l

24.00

941

3056

Autoimmune diseases related-to ILD

1430

4848

2.50

212.02

1.1

1.52

1.50

g/l

1.74

1335

4434

Asthma (mode)

1238

2298

2.87

210.13

1.1

1.45

1.50

g/l

2.60

1158

2107

Asthma, unspecified (mode), excluding more controls

885

1971

3.27

205.27

1.1

1.47

1.49

g/l

0.36

820

1805

1071

3464

2.82

203.27

1.1

1.64

1.48

g/l

24.95

957

3200

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1595

4574

2.38

202.75

1.1

1.57

1.48

g/l

12.78

1476

4196

1105

3549

2.76

200.84

1.1

1.63

1.48

g/l

24.46

989

3276

Diseases of oesophagus, stomach and duodenum

1684

4306

2.34

198.53

1.1

1.53

1.49

g/l

3.37

1539

3966

Early onset COPD, excluding more controls

438

911

4.97

196.66

1.1

1.55

1.53

g/l

0.24

401

828

Autoimmune diseases excluding thyroid diseases

1654

3844

2.36

194.48

1.1

1.53

1.49

g/l

4.20

1540

3522

Asthma, unspecified (mode)

897

2120

3.11

192.06

1.1

1.48

1.50

g/l

0.70

831

1947

Heart failure, not strict

1226

3182

2.64

191.12

1.1

1.63

1.49

g/l

22.64

1136

2895

Autoimmune diseases excluding thyroid diseases, strict definition

1610

3746

2.37

190.56

1.1

1.54

1.49

g/l

4.20

1498

3431

Transplanted organ and tissue status

328

551

6.36

188.24

1.4

1.1

1.57

1.48

g/l

2.99

318

506

Abnormalities of breathing

1403

3296

2.47

183.87

1.1

1.48

1.50

g/l

1.42

1294

3023

Anaemias

460

585

5.17

183.75

1.1

1.61

1.39

g/l

17.64

429

545

Noninfective enteritis and colitis

888

3120

2.91

182.92

1.1

1.50

1.49

g/l

0.20

840

2848

Cholangitis (primary sclerosing, PSC), with reimbursement 202

152

19.08

180.43

1.2

1.1

1.56

1.47

g/l

1.55

142

Other diseases of biliary tract

263

370

7.55

178.51

1.2

1.1

1.62

1.52

g/l

2.81

250

334

Inflammatory bowel disease

680

2094

3.34

177.15

1.1

1.49

g/l

0.16

648

1912

5-aminosalicylic acid

482

1188

4.19

174.90

1.1

1.48

g/l

0.00

456

1077

Hernia of abdominal wall, postoperative

304

502

6.17

173.85

1.1

1.53

1.42

g/l

3.48

277

451

Primary biliary cholangitis (PBC)

144

19.00

173.53

1.1

1.52

1.49

g/l

0.29

130

L04AD Calcineurin inhibitors

347

667

5.54

172.46

1.3

1.1

1.55

1.49

g/l

1.87

336

603

Other chronic obstructive pulmonary disease

711

1815

3.28

171.44

1.1

1.57

g/l

0.04

645

1639

Asthma-related infections

983

3729

2.61

165.07

1.1

1.48

1.51

g/l

1.17

918

3407

Asthma, hospital admission 2, infections

983

3729

2.61

165.07

1.1

1.48

1.51

g/l

1.17

918

3407

Asthma (diagnoses ohter than nonallergic)

1384

4984

2.27

165.06

1.1

1.46

1.51

g/l

4.08

1291

4558

IBD patients in KELA-register

538

1494

3.72

165.00

1.1

1.48

g/l

0.14

512

1364

Asthma, hospital admissions , main diagnosis only

1306

4987

2.31

164.16

1.1

1.45

1.51

g/l

7.03

1214

4566

Tramadol

1241

3110

2.43

160.17

1.1

1.54

1.47

g/l

6.45

1143

2858

Inflammatory bowel disease, strict (require KELA)

538

1535

3.62

158.44

1.1

1.48

1.49

g/l

0.21

512

1402

Budesonide

346

716

5.03

156.98

1.1

1.52

1.49

g/l

0.46

324

648

COPD (mode)

524

1093

3.83

156.97

1.1

1.57

1.54

g/l

0.93

473

991

Asthma, including avohilmo

1737

4697

2.06

148.11

1.1

1.46

1.52

g/l

7.63

1617

4293

Any reimbursement code in KELA

821

1404

2.97

145.54

1.1

1.48

1.42

g/l

4.53

766

1275

Autoimmune diseases

1599

3868

2.12

144.01

1.1

1.51

1.49

g/l

1.37

1481

3545

Dyspnoea

1361

4555

2.18

143.96

1.1

1.49

1.52

g/l

1.37

1264

4171

Colitis, primary sclerosing

120

19.13

141.89

1.2

1.1

1.57

1.43

g/l

1.86

114

Ulcerative colitis

516

1546

3.44

140.69

1.1

1.48

1.49

g/l

0.40

490

1408

ILD medications: azathioprine

338

751

4.67

140.64

1.1

1.54

1.47

g/l

1.94

325

679

Other chronic obstructive pulmonary disease, including avohilmo

836

2648

2.64

137.79

1.1

1.55

1.54

g/l

0.20

761

2425

COPD, hospital admissions

710

2130

2.86

137.39

1.1

1.57

1.55

g/l

0.51

646

1928

COPD, early/later onset

714

2144

2.85

136.85

1.1

1.57

1.55

g/l

0.52

648

1943

Azathioprine

338

771

4.55

136.08

1.1

1.54

1.48

g/l

1.79

325

697

Asthma/COPD (KELA code 203)

1371

4329

2.14

135.74

1.1

1.46

1.51

g/l

4.66

1270

3958

Symptoms and signs involving the digestive system and abdomen

1398

3245

2.18

134.64

1.1

1.53

1.48

g/l

3.72

1281

2983

Implicit bacterial Sepsis

664

1986

2.92

133.92

1.1

1.66

1.50

g/l

15.25

611

1804

Implicit Sepsis

1139

3734

2.28

133.86

1.1

1.61

1.49

g/l

16.40

1039

3420

Acute renal failure

420

1138

3.80

133.40

1.1

1.71

1.52

g/l

11.85

389

1027

750

2836

2.67

132.15

1.1

1.47

1.50

g/l

1.36

702

2593

Bacterial Sepsis

739

2262

2.75

132.15

1.1

1.66

1.50

g/l

16.57

684

2066

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

727

1627

2.87

130.37

1.2

1.1

1.56

1.44

g/l

9.90

681

1492

Implicit bacterial Sepsis, including avohilmo

711

2169

2.77

129.68

1.1

1.66

1.50

g/l

15.64

657

1976

Renal failure

729

2335

2.71

127.50

1.1

1.68

1.52

g/l

14.96

678

2109

COPD, hospital admissions 1, only main diagnosis

548

1517

3.17

127.27

1.1

1.55

1.56

g/l

0.06

497

1373

Unspecified jaundice

161

190

9.06

127.07

1.1

1.67

1.48

g/l

4.95

151

175

L04AA Selective immunosuppressants

477

1453

3.39

126.91

1.2

1.1

1.56

1.49

g/l

2.46

456

1323

Implicit Sepsis, including avohilmo

1216

4049

2.17

126.78

1.1

1.60

1.48

g/l

15.35

1112

3708

Asthma-related pneumonia or sepsis

587

2008

2.97

126.47

1.1

1.52

1.53

g/l

0.40

547

1814

Asthma, hospital admissions 3, pneumonia

587

2008

2.97

126.47

1.1

1.52

1.53

g/l

0.40

547

1814

Condition for Implicit Sepsis (Organ dysfunction codes)

1257

4106

2.15

126.36

1.1

1.60

1.48

g/l

17.37

1149

3765

Asthma-related pneumonia

585

2004

2.97

125.73

1.1

1.52

1.54

g/l

0.38

545

1810

Cholelithiasis, broad definition with cholecystitis

1208

3734

2.18

124.92

1.1

1.51

g/l

0.08

1125

3415

Early onset COPD

438

1285

3.52

123.62

1.1

1.55

1.52

g/l

0.65

401

1179

Examination and observation for other reasons

859

1903

2.58

123.12

1.1

1.50

1.51

g/l

0.36

804

1762

Used for control exclusion in common control thyroid runs

1455

3602

2.06

121.29

1.1

1.50

1.49

g/l

0.65

1343

3299

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1308

4293

2.08

120.66

1.1

1.59

1.47

g/l

16.91

1197

3940

Malignant neoplasm of digestive organs, including Hilmo

696

1898

2.75

120.60

1.2

1.1

1.65

1.52

g/l

9.99

653

1719

Cholelithiasis

1159

3676

2.18

120.45

1.1

1.51

g/l

0.06

1078

3357

Abnormal findings on diagnostic imaging of lung

715

2677

2.57

115.86

1.1

1.52

1.54

g/l

0.65

668

2438

Other bacterial diseases, including avohilmo

1447

4600

1.98

115.49

1.1

1.60

1.46

g/l

24.75

1349

4207

Non-allergic asthma (mode), excluding more controls

324

804

4.09

114.54

1.1

1.46

1.49

g/l

0.67

302

729

Symptoms and signs involving the circulatory and respiratory systems

1350

3306

2.07

113.75

1.1

1.48

1.50

g/l

1.18

1250

3033

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

372

1039

3.71

113.44

1.1

1.46

1.49

g/l

0.84

353

945

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

458

626

3.72

113.36

1.1

1.0

1.47

1.45

g/l

0.53

421

583

Type 2 diabetes, wide definition

1101

3218

2.18

113.05

1.1

1.56

1.50

g/l

4.29

1012

2943

Other diseases of intestines

1488

4258

1.97

112.68

1.1

1.51

1.49

g/l

1.03

1377

3919

Fever of other and unknown origin

845

3139

2.36

112.31

1.1

1.60

1.49

g/l

11.75

799

2874

General symptoms and signs

1474

3751

1.99

111.94

1.1

1.52

1.48

g/l

3.00

1353

3433

Obesity related asthma

597

2214

2.75

111.65

1.1

1.46

1.52

g/l

3.04

552

2009

Diseases of the digestive system

703

2799

2.53

111.53

1.1

1.57

1.51

g/l

2.70

649

2544

Ulcerative colitis (strict definition, require KELA)

376

1072

3.63

111.13

1.1

1.46

1.49

g/l

0.76

356

973

Ulcerative colitis, NAS

319

814

4.07

110.84

1.1

1.46

1.50

g/l

1.00

300

741

Mucosal proctocolitis

309

771

4.17

110.82

1.1

1.48

1.49

g/l

0.13

294

700

Other bacterial diseases

1349

4529

1.99

110.68

1.1

1.62

1.47

g/l

25.80

1260

4134

Iron deficiency anaemia

660

2528

2.60

110.53

1.1

1.63

1.51

g/l

9.69

604

2306

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

392

1160

3.49

109.34

1.1

1.47

1.49

g/l

0.55

371

1057

Dental caries

478

1497

3.08

108.23

1.2

1.1

1.58

1.51

g/l

2.60

441

1391

Non-allergic asthma (mode)

324

840

3.91

107.80

1.1

1.46

1.50

g/l

0.97

302

763

Crohn disease

304

765

4.13

107.74

1.1

1.51

1.49

g/l

0.25

292

691

Nutritional anaemias

731

2885

2.45

107.40

1.1

1.62

1.51

g/l

9.44

670

2630

Second line medication for Crohn's disease

909

4149

2.22

107.13

1.1

1.52

1.49

g/l

1.20

863

3792

Septicaemia

633

2228

2.63

106.79

1.1

1.66

1.50

g/l

13.74

588

2019

Explicit Sepsis

651

2334

2.58

105.49

1.1

1.66

1.49

g/l

14.79

605

2120

Other septicaemia

568

1986

2.74

104.63

1.1

1.67

1.50

g/l

13.43

529

1792

Explicit Sepsis, including avohilmo

662

2392

2.55

104.40

1.1

1.66

1.49

g/l

14.91

612

2180

Malignant neoplasm of digestive organs

607

1745

2.71

103.67

1.2

1.1

1.65

1.53

g/l

8.37

571

1577

Other septicaemia, including avohilmo

577

2041

2.70

102.86

1.1

1.67

1.50

g/l

13.21

536

1845

Other gastritis (incl. Duodenitis)

377

1130

3.42

102.69

1.1

1.58

1.52

g/l

2.06

341

1030

COPD related to multimorbidity

572

1808

2.72

101.14

1.1

1.59

1.55

g/l

0.87

519

1630

Medical observation and evaluation for suspected diseases and conditions

872

1911

2.36

101.07

1.1

1.48

1.51

g/l

1.57

786

1770

Haemorrhage from respiratory passages

503

1567

2.89

100.72

1.1

1.58

1.55

g/l

0.91

464

1414

Gastro-oesophageal reflux disease

957

3812

2.14

100.23

1.1

1.51

1.50

g/l

0.27

867

3508

Type 2 diabetes

1327

3980

1.95

99.13

1.1

1.52

1.49

g/l

2.68

1223

3651

Bronchiectasis

184

329

5.86

98.73

1.1

1.49

1.55

g/l

1.01

174

299

COPD, hospital admission 2, with asthma infections

474

1402

2.97

98.62

1.1

1.61

1.55

g/l

1.93

431

1268

Insulin medication

852

3205

2.23

98.56

1.1

1.61

1.50

g/l

10.04

776

2940

Metabolic disorders

1318

4124

1.94

97.45

1.1

1.51

1.50

g/l

0.26

1210

3779

Diabetes, varying definitions

1365

4175

1.91

96.75

1.1

1.52

1.48

g/l

2.97

1256

3837

Other pulmonary diagnosis

990

2289

2.19

96.40

1.1

1.50

g/l

0.02

913

2103

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

213

275

5.60

95.81

1.1

1.56

1.49

g/l

1.48

189

258

Bacterial infection, other or unspecified, including avohilmo

820

3038

2.24

95.26

1.1

1.65

1.49

g/l

16.27

766

2751

Excluding asthma or asthma-COPD overlap

985

2289

2.18

94.76

1.1

1.50

g/l

0.05

907

2103

Caries of dentine

416

1333

3.08

94.59

1.2

1.1

1.58

1.51

g/l

2.36

379

1238

Diabetes mellitus

1363

4182

1.90

94.50

1.1

1.52

1.48

g/l

2.76

1255

3843

GI-bleeding

481

1738

2.82

94.48

1.1

1.60

1.53

g/l

2.46

444

1574

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1273

3932

1.94

94.36

1.1

1.53

1.48

g/l

3.44

1176

3608

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1209

3610

1.98

94.29

1.1

1.56

1.49

g/l

5.68

1117

3307

1209

3610

1.98

94.29

1.1

1.56

1.49

g/l

5.68

1117

3307

Other nutritional deficiencies

994

4490

2.05

93.57

1.1

1.51

1.50

g/l

0.58

907

4144

Aplastic and other anaemias

645

2453

2.44

93.25

1.1

1.65

1.53

g/l

9.42

589

2237

Other diseases of the digestive system

479

1744

2.80

92.78

1.2

1.1

1.59

1.53

g/l

2.22

444

1581

Abdominal and pelvic pain

1258

3245

1.96

92.75

1.1

1.51

1.48

g/l

1.60

1156

2983

Substance abuse, excluding more controls

837

3234

2.19

92.48

1.1

1.61

1.50

g/l

10.58

740

2996

Influenza and pneumonia

1443

4877

1.84

92.45

1.1

1.56

1.48

g/l

8.67

1336

4471

Dialysis, with operation codes

269

694

4.02

92.18

1.2

1.1

1.65

1.49

g/l

6.33

261

629

Bleeding

1139

4090

1.97

92.13

1.1

1.57

1.51

g/l

5.30

1043

3742

Other and unspecified anaemias

600

2285

2.50

91.94

1.1

1.64

1.53

g/l

7.65

547

2081

Endocrine, nutritional and metabolic diseases

1041

2526

2.10

91.91

1.1

1.48

1.47

g/l

0.21

965

2342

Cardiovascular diseases (excluding rheumatic etc)

884

2309

2.21

91.88

1.1

1.50

1.42

g/l

7.02

827

2134

Opioids

1270

3404

1.94

91.65

1.1

1.51

1.46

g/l

3.85

1177

3133

Other anaemias

603

2302

2.49

91.28

1.1

1.64

1.53

g/l

7.77

550

2097

Renal tubulo-interstitial diseases

1180

4519

1.93

90.71

1.1

1.62

1.49

g/l

17.97

1097

4130

COPD differential diagnosis

975

2298

2.15

90.67

1.1

1.50

g/l

0.06

900

2107

ILD differential diagnosis

974

2298

2.14

90.33

1.1

1.50

g/l

0.06

899

2107

Hypertensive diseases (excluding secondary)

741

1845

2.37

89.88

1.1

1.49

1.43

g/l

4.66

680

1698

Type 2 diabetes, definitions combined

1248

3829

1.91

88.73

1.1

1.52

1.49

g/l

2.00

1148

3512

Bacterial infection, other or unspecified

741

2800

2.26

88.69

1.2

1.1

1.66

1.50

g/l

16.34

690

2542

6-mercaptopurine

122

160

8.18

88.41

1.1

1.48

1.47

g/l

0.11

116

143

Type 2 diabetes, strict (exclude DM1)

1253

3857

1.91

88.24

1.1

1.52

1.49

g/l

1.72

1153

3539

All kidney diseases

1323

4824

1.85

88.13

1.1

1.58

1.48

g/l

13.10

1225

4421

Pain in throat and chest

1086

3242

2.00

88.09

1.1

1.49

1.51

g/l

0.44

1003

2977

Diabetes, insulin treatment (Kela reimbursement)

1340

4323

1.86

88.04

1.1

1.53

1.49

g/l

3.44

1240

3958

Other diseases of pleura

617

2243

2.43

87.06

1.1

1.59

1.54

g/l

1.70

570

2032

Type 2 diabetes, definitions combined, including avohilmo

1247

3833

1.90

86.41

1.1

1.52

1.49

g/l

1.81

1150

3516

Insulin, combination of fast acting with intermediate-acting or long-acting

852

3718

2.10

86.34

1.1

1.61

1.51

g/l

9.38

776

3409

Pneumonias (Asthma/COPD co-morbidities)

1369

4948

1.82

86.00

1.1

1.57

1.48

g/l

10.31

1270

4540

Infections, IBD-co-morbidities

273

484

4.05

85.74

1.2

1.1

1.60

1.49

g/l

2.99

248

452

Reimbursement for rheumatic diseases

817

3889

2.12

85.32

1.1

1.53

1.50

g/l

1.68

761

3548

Insulin, intermediate and long-acting

772

3494

2.16

84.65

1.1

1.61

1.51

g/l

8.67

704

3204

All pneumoniae

1372

4967

1.81

84.19

1.1

1.56

1.48

g/l

9.52

1273

4556

Nephropathy related operations

263

713

3.83

84.08

1.2

1.1

1.65

1.51

g/l

5.14

255

650

Pneumonia, organism unspecified

1248

4665

1.85

83.22

1.1

1.58

1.48

g/l

10.43

1154

4278

Other disorders of fluid, electrolyte and acid-base balance

463

1650

2.69

82.15

1.1

1.66

1.53

g/l

7.18

419

1501

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1277

4430

1.84

81.88

1.1

1.56

1.50

g/l

5.46

1177

4058

Diabetes medication

1353

4397

1.81

81.50

1.1

1.53

1.48

g/l

3.51

1243

4046

Obesity due to excess calories

722

3363

2.18

81.34

1.1

1.50

g/l

0.16

661

3105

Obesity and other hyperalimentation

918

4376

2.00

81.09

1.1

1.50

g/l

0.16

833

4040

Ulcerative colitis (strict definition, all Crohn cases excluded)

293

873

3.46

80.99

1.1

1.46

1.50

g/l

0.94

277

794

Cholecystectomy

943

4074

1.99

80.94

1.1

1.50

1.52

g/l

0.49

877

3708

Obesity

914

4362

2.00

80.83

1.1

1.50

g/l

0.17

829

4027

Chronic kidney disease

431

1531

2.75

80.58

1.1

1.65

1.52

g/l

6.44

401

1376

Dipeptidyl peptidase 4 (DPP-4) inhibitors

716

2564

2.22

80.58

1.1

1.59

1.53

g/l

3.17

654

2347

Other and unspecified iron deficiency

499

1996

2.54

79.69

1.1

1.63

1.51

g/l

8.04

459

1809

Mental and behavioural disorders due to psychoactive substance use

862

3946

2.02

79.00

1.1

1.61

1.49

g/l

11.81

764

3650

Nausea and vomiting

384

1319

2.89

78.72

1.1

1.53

1.49

g/l

1.19

357

1209

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1327

4987

1.79

78.52

1.1

1.57

1.48

g/l

10.57

1232

4576

Cough

558

2211

2.39

77.32

1.1

1.48

1.51

g/l

1.36

527

2013

L04AX Other immunosuppressants

816

4057

2.04

77.06

1.1

1.52

1.49

g/l

1.48

774

3711

Substance abuse

837

3890

2.02

76.74

1.1

1.61

1.49

g/l

12.69

740

3600

Cardiovascular diseases

806

2015

2.14

76.13

1.1

1.50

1.42

g/l

6.46

754

1857

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1289

4596

1.79

75.50

1.1

1.55

1.49

g/l

5.07

1203

4206

Chronic gastritis

361

1267

2.90

75.03

1.1

1.55

1.53

g/l

0.32

322

1154

Heart failure and antihypertensive medication

360

767

3.10

75.02

1.1

1.65

1.49

g/l

7.54

335

691

Other (not insulin) diabetes medications

1241

4083

1.80

73.12

1.1

1.53

1.49

g/l

2.11

1139

3749

Later onset COPD, excluding more controls

266

578

3.57

72.49

1.0

1.1

1.61

1.57

g/l

0.69

238

515

Heart failure,strict

646

2040

2.24

72.44

1.1

1.67

1.50

g/l

15.51

606

1849

Codeine

1135

3347

1.85

71.49

1.1

1.52

1.46

g/l

5.15

1043

3080

Certain infectious and parasitic diseases

1200

3337

1.82

70.20

1.1

1.53

1.46

g/l

6.24

1111

3047

Other heart diseases

638

1889

2.22

69.23

1.1

1.54

1.42

g/l

9.03

597

1742

Asthma and opportunity respiratory infection

123

212

6.15

68.92

1.1

1.45

1.56

g/l

1.73

117

194

Chronic hepatitis NAS

13.24

68.62

1.1

1.63

1.50

g/l

1.45

General examination and investigation of persons without complaint and reported diagnosis

764

1911

2.09

67.82

1.1

1.50

1.51

g/l

0.22

700

1770

Implicit viral Sepsis, including avohilmo

413

1645

2.54

66.60

1.2

1.1

1.58

1.49

g/l

3.23

382

1493

Gastroduodenal ulcer

336

1208

2.82

66.36

1.1

1.64

1.54

g/l

3.86

306

1093

Oxycodone

518

1936

2.32

66.07

1.1

1.70

1.50

g/l

14.95

474

1768

Persons encountering health services in other circumstances

576

2655

2.17

64.79

1.1

1.55

1.49

g/l

2.81

542

2428

Persons encountering health services in other circumstances, wide

1422

4372

1.68

64.76

1.1

1.52

1.50

g/l

0.89

1313

3994

Depression medications

372

649

2.92

64.61

1.1

1.45

1.38

g/l

2.41

343

603

Other Crohn's disease

164

383

4.47

64.52

1.2

1.1

1.49

1.45

g/l

0.69

157

349

All chronic kidney diseases

708

2810

2.03

64.01

1.1

1.63

1.50

g/l

11.41

658

2554

Acute pancreatitis

293

1008

2.97

63.39

1.1

1.60

1.51

g/l

2.90

263

921

Sleep apnoea

1222

4519

1.72

62.68

1.1

1.47

1.52

g/l

3.72

1116

4147

Other special examinations and investigations of persons without complaint or reported diagnosis

761

1911

2.03

62.30

1.1

1.50

1.51

g/l

0.43

706

1770

Oedema, not elsewhere classified

442

1830

2.39

62.24

1.1

1.58

1.50

g/l

2.98

404

1655

Viral hepatitis, IBD co-morbidity

127

248

5.32

61.89

1.1

1.66

1.46

g/l

4.51

117

230

Hypertension, essential

995

3101

1.83

61.54

1.1

1.51

1.48

g/l

1.56

912

2842

Other respiratory diseases principally affecting the interstitium

270

904

3.05

61.38

1.1

1.58

1.55

g/l

0.64

241

821

Benign neoplasm: Colon

684

3244

2.00

61.20

1.2

1.1

1.55

1.54

g/l

0.24

620

2957

Benign neoplasm of colon, rectum, anus and anal canal

796

3576

1.90

60.22

1.1

1.55

1.54

g/l

0.49

719

3271

Other interstitial pulmonary diseases

239

755

3.24

60.09

1.1

1.57

1.55

g/l

0.27

213

681

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

287

1008

2.91

59.89

1.1

1.66

1.51

g/l

5.19

272

903

COPD/asthma/ILD related infections

1229

3610

1.72

59.85

1.1

1.52

1.49

g/l

2.13

1126

3307

COPD/asthma related infections

1229

3610

1.72

59.85

1.1

1.52

1.49

g/l

2.13

1126

3307

Interstitial lung disease endpoints

239

757

3.23

59.83

1.1

1.57

1.55

g/l

0.24

213

683

Interstitial lung disease

239

757

3.23

59.83

1.1

1.57

1.55

g/l

0.24

213

683

Other medical care

634

2623

2.05

59.55

1.1

1.69

1.50

g/l

15.98

581

2367

Complications of surgical and medical care, not elsewhere classified

1239

4951

1.68

59.53

1.1

1.55

1.50

g/l

4.26

1134

4550

ILD, hospital admissions

237

750

3.24

59.43

1.1

1.57

1.55

g/l

0.26

211

678

Mental and behavioural disorders due to alcohol

702

3452

1.96

59.23

1.1

1.62

1.49

g/l

12.11

618

3198

Persons encountering health services for specific procedures and health care

1345

4835

1.65

59.07

1.1

1.56

1.47

g/l

8.79

1238

4436

Sleep apnoea, including avohilmo

1262

4579

1.68

59.05

1.1

1.46

1.52

g/l

4.84

1152

4199

Hypertensive diseases

1004

3175

1.80

58.81

1.1

1.51

1.47

g/l

2.25

925

2912

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1355

4372

1.66

58.80

1.1

1.50

g/l

0.13

1257

3994

Hypertension

1003

3173

1.80

58.65

1.1

1.51

1.47

g/l

2.31

924

2910

Other antidepressants

1247

3781

1.70

58.27

1.1

1.52

1.50

g/l

0.62

1139

3488

Continuous positive airway pressure

248

661

3.18

58.06

1.1

1.53

1.46

g/l

1.71

214

622

Malaise and fatigue

649

2552

2.02

57.99

1.1

1.58

1.49

g/l

6.02

603

2314

Benign neoplasm of other and ill-defined parts of digestive system

280

992

2.89

57.58

1.1

1.52

1.53

g/l

0.13

256

897

Biguanides

1164

4154

1.70

57.57

1.1

1.53

1.50

g/l

1.59

1071

3814

COPD-related respiratory insufficiency

190

534

3.65

57.52

1.1

1.59

1.56

g/l

0.36

170

489

Gastric ulcer

240

780

3.13

57.37

1.1

1.64

1.54

g/l

2.95

216

708

Mental and behavioural disorders due to alcohol, excluding acute intoxication

626

3125

2.01

57.25

1.1

1.63

1.50

g/l

10.23

547

2896

Mood disorders, excluding more controls

1159

4039

1.70

56.35

1.1

1.50

1.49

g/l

0.11

1055

3731

Undetermined asthma, excluding more controls

198

578

3.49

56.34

1.1

1.43

1.50

g/l

1.78

185

520

COPD, hospital admissions 3, with asthma pneumonia sepsis

335

1110

2.62

55.92

1.1

1.62

1.56

g/l

1.46

306

1016

Other respiratory disorders and diseases

287

1048

2.79

55.62

1.1

1.56

1.53

g/l

0.63

262

947

Other diseases of the respiratory system

287

1048

2.79

55.62

1.1

1.56

1.53

g/l

0.63

262

947

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

453

2047

2.25

55.39

1.1

1.54

1.50

g/l

1.45

416

1879

Glucagon-like peptide-1 (GLP-1) analogues

453

2047

2.25

55.39

1.1

1.54

1.50

g/l

1.45

416

1879

Iron deficiency anaemia secondary to blood loss (chronic)

241

806

3.05

54.95

1.1

1.65

1.52

g/l

4.89

219

734

Other diseases of pancreas

156

397

4.06

54.65

1.1

1.52

1.51

g/l

0.19

141

359

Anxiety disorders, excluding more controls

1036

3869

1.72

54.09

1.1

1.49

g/l

0.18

944

3571

Other noninfective gastroenteritis and colitis

355

1459

2.47

53.92

1.1

1.50

g/l

0.04

332

1320

Antihypertensive medication - note that there are other indications

738

2001

1.94

53.83

1.1

1.47

1.43

g/l

1.55

689

1835

Heart failure, strict

678

2434

1.96

53.77

1.1

1.67

1.53

g/l

13.22

631

2206

Other disorders of skin and subcutaneous tissue

905

4376

1.76

53.55

1.1

1.56

1.51

g/l

3.54

829

4005

Constipation

1105

4489

1.68

53.16

1.1

1.54

1.50

g/l

1.89

1008

4119

Undetermined asthma

198

600

3.37

53.15

1.1

1.43

1.51

g/l

2.18

185

543

Viral Sepsis

287

1074

2.72

53.03

1.1

1.61

1.49

g/l

3.96

264

972

Neoplasms

932

2757

1.79

52.65

1.1

1.51

1.46

g/l

3.14

872

2540

Alcohol use disorder, ICD-based

576

2906

2.01

52.61

1.1

1.63

1.50

g/l

9.37

503

2686

Implicit viral Sepsis

286

1073

2.71

52.58

1.1

1.61

1.49

g/l

3.99

263

971

Other diseases of blood and blood-forming organs, wide

328

1329

2.52

51.61

1.1

1.59

1.51

g/l

2.78

305

1202

Complications of procedures, not elsewhere classified

998

4776

1.70

51.37

1.1

1.54

1.50

g/l

2.68

916

4389

1328

4206

1.61

51.02

1.1

1.52

1.50

g/l

0.61

1222

3850

170

484

3.63

50.69

1.1

1.77

1.56

g/l

6.28

145

445

Depression or dysthymia

826

2490

1.83

50.61

1.1

1.50

g/l

0.06

755

2290

Cardiac arrhythmias

715

2446

1.89

50.52

1.1

1.51

1.45

g/l

3.09

665

2257

Intestinal infectious diseases, including avohilmo, including avohilmo

1386

4912

1.58

50.40

1.1

1.53

1.49

g/l

2.74

1286

4495

Any death

772

2976

1.83

50.37

1.1

1.71

1.50

g/l

25.41

693

2735

All-cause Heart Failure

658

2399

1.93

50.05

1.1

1.67

1.52

g/l

12.80

613

2173

Chronic pancreatitis

201

640

3.22

50.02

1.1

1.65

1.49

g/l

4.93

185

585

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1238

4963

1.61

49.99

1.1

1.52

1.49

g/l

1.00

1148

4544

Ischemic heart diseases

1018

3594

1.70

49.80

1.1

1.53

1.50

g/l

1.17

939

3277

Other ulcerative colitis

130

313

4.33

49.26

1.2

1.1

1.50

1.48

g/l

0.20

121

284

Other soft tissue disorders, not elsewhere classified

1130

3919

1.65

49.19

1.1

1.51

1.50

g/l

0.18

1017

3614

Diseases of the skin and subcutaneous tissue

1160

3551

1.65

48.93

1.1

1.50

1.49

g/l

0.59

1062

3258

Exposure to unspecified factor

1243

5338

1.59

48.70

1.1

1.51

1.50

g/l

0.39

1151

4893

Coronary revascularization (ANGIO or CABG)

961

3434

1.71

48.64

1.1

1.52

1.51

g/l

0.21

889

3130

Covid-19 confirmed case

475

2298

2.09

48.54

1.1

1.56

1.52

g/l

1.58

438

2091

Percutaneous Coronary Intervention

958

3430

1.71

48.38

1.1

1.52

1.51

g/l

0.18

886

3128

Diseases of arteries, arterioles and capillaries (FINNGEN)

293

766

2.68

48.23

1.1

1.61

1.46

g/l

5.80

268

698

Depression

1185

4960

1.61

48.01

1.1

1.50

g/l

0.00

1079

4565

Mood [affective] disorders

1248

5060

1.59

47.86

1.1

1.50

g/l

0.06

1138

4654

Crohn disease (strict definition, require KELA, min 2 HDR)

142

374

3.95

47.61

1.1

1.49

1.47

g/l

0.28

136

343

Mood disorders

1248

5064

1.59

47.34

1.1

1.50

g/l

0.04

1138

4658

Hypothyroidism (congenital or acquired)

294

611

2.72

47.22

1.1

1.48

1.38

g/l

3.71

263

570

Insulin, fast-acting

472

2305

2.07

47.17

1.1

1.60

1.49

g/l

6.32

434

2108

Acute pancreatitis (for exclusion)

293

1178

2.53

46.92

1.1

1.60

1.51

g/l

2.89

263

1079

Dermatitis and eczema

1346

5141

1.56

46.80

1.1

1.51

1.50

g/l

0.45

1246

4710

Respiratory insufficiency

121

285

4.34

46.69

1.1

1.58

1.55

g/l

0.31

110

255

Polyarthropathies

848

3141

1.75

46.65

1.1

1.56

1.51

g/l

2.98

790

2889

Crohn disease (strict definition, require KELA)

142

380

3.88

46.54

1.1

1.49

1.46

g/l

0.32

136

348

Hypothyroidism and >3 levothyroxin purchases

291

608

2.71

46.40

1.1

1.48

1.38

g/l

3.65

261

567

Hypothyroidism, levothyroxine purchases

291

608

2.71

46.40

1.1

1.48

1.38

g/l

3.65

261

567

Complications of medical and surgical care

893

4783

1.69

46.32

1.1

1.54

1.51

g/l

1.75

812

4391

ILD, hospital admission 2, with pulmonary infections

151

422

3.67

46.18

1.1

1.62

1.54

g/l

0.99

134

383

Persons encountering health services for examination and investigation

707

1911

1.87

45.69

1.1

1.51

g/l

0.09

648

1770

Major coronary heart disease event

1003

3635

1.66

45.39

1.1

1.53

1.51

g/l

0.80

923

3308

ILD, hospital admissions 1, main diag only

203

689

3.01

45.27

1.1

1.58

1.55

g/l

0.36

180

625

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

148

416

3.69

45.13

1.1

1.48

1.46

g/l

0.41

142

383

Diarrhoea and gastroenteritis of presumed infectious origin

860

4570

1.69

44.81

1.1

1.52

1.49

g/l

1.64

812

4184

Crohn's disease NAS

134

354

3.92

44.71

1.1

1.52

1.48

g/l

0.61

129

323

Allergic asthma (mode), excluding more controls

284

1119

2.51

44.66

1.1

1.42

1.47

g/l

1.65

270

1020

Neurotic, stress-related and somatoform disorders

1105

4782

1.60

44.45

1.1

1.49

g/l

0.22

1006

4405

Hard cardiovascular diseases

1012

3649

1.65

44.43

1.1

1.53

1.50

g/l

1.41

931

3332

Diverticular disease of intestine

826

2984

1.74

44.19

1.1

1.52

g/l

0.02

756

2732

Disorders of mineral metabolism

154

451

3.52

43.99

1.1

1.56

1.51

g/l

0.67

145

408

Anxiety disorders

1111

4806

1.60

43.97

1.1

1.49

g/l

0.24

1011

4428

Other heart diseases, wide

1115

4244

1.60

43.51

1.1

1.53

1.47

g/l

4.00

1032

3900

Intestinal infectious diseases

1133

5371

1.58

43.36

1.1

1.54

1.49

g/l

2.86

1065

4908

Emergency coronary revascularization (for ACS)

996

3684

1.64

43.26

1.1

1.52

g/l

0.02

920

3349

Atrial fibrillation and flutter with reimbursement

297

747

2.54

43.11

1.1

1.57

1.47

g/l

3.47

283

678

Viral hepatitis, including avohilmo

156

468

3.45

43.02

1.1

1.66

1.46

g/l

6.51

144

429

Other viral hepatitis, including avohilmo

145

417

3.61

42.76

1.1

1.67

1.44

g/l

7.21

134

384

Codeine or tramadol medication

1314

4659

1.54

42.64

1.1

1.53

1.49

g/l

2.32

1199

4282

Crohn's disease of small intestine

141

399

3.66

42.55

1.1

1.50

1.47

g/l

0.41

135

363

Allergic asthma (mode)

284

1145

2.45

42.54

1.1

1.42

1.48

g/l

2.07

270

1046

Atrial fibrillation and flutter

370

1064

2.27

42.52

1.1

1.56

1.45

g/l

4.87

351

969

Diseases of the respiratory system

679

1854

1.85

42.48

1.1

1.51

1.50

g/l

0.14

621

1696

Pain in joint

686

2354

1.80

41.70

1.1

1.49

1.51

g/l

0.44

614

2163

Abnormalities of heart beat

404

1890

2.09

41.53

1.1

1.47

1.51

g/l

1.14

373

1713

Other acute lower respiratory infections

649

3492

1.78

41.30

1.1

1.51

1.50

g/l

0.26

595

3204

Insulin, fast-acting or short human

472

2427

1.97

40.88

1.1

1.60

1.50

g/l

5.70

434

2215

Bronchitis

1266

4991

1.53

40.67

1.1

1.51

1.50

g/l

0.57

1160

4586

Other symptoms and signs involving the digestive system and abdomen

223

843

2.69

40.54

1.1

1.49

1.50

g/l

0.07

195

769

Abnormal findings on diagnostic imaging of other body structures

207

759

2.78

40.05

1.1

1.54

1.52

g/l

0.21

196

691

Unspecified kidney failure

149

455

3.35

39.76

1.1

1.63

1.50

g/l

2.89

139

412

Erysipelas, including avohilmo

840

3773

1.66

39.62

1.1

1.60

1.48

g/l

12.88

777

3432

Gout

340

1331

2.22

39.54

1.1

1.63

1.55

g/l

1.97

317

1209

Acute upper respiratory infections

1201

4720

1.53

39.02

1.1

1.50

1.51

g/l

0.58

1105

4316

Gout, FINNGEN

340

1567

2.18

39.00

1.1

1.63

1.54

g/l

2.57

317

1415

Other viral hepatitis

134

389

3.57

39.00

1.1

1.67

1.44

g/l

6.96

123

361

Neurological diseases, wide definition

348

764

2.31

38.93

1.1

1.46

g/l

0.02

323

723

Any mental disorder

1246

4095

1.53

38.86

1.1

1.52

1.49

g/l

1.66

1127

3780

Irritable bowel syndrome

350

1649

2.15

38.67

1.1

1.44

1.49

g/l

1.54

316

1501

Benign neoplasms

1134

3997

1.55

38.23

1.1

1.50

g/l

0.04

1040

3682

Sleep disorders (combined)

1251

4323

1.52

37.94

1.1

1.48

1.51

g/l

1.96

1146

3970

Collagenous colitis

151

480

3.23

37.85

1.1

1.49

1.51

g/l

0.28

143

434

Pain (limb, back, neck, head abdominally)

805

2399

1.69

37.57

1.1

1.50

1.51

g/l

0.12

739

2209

Non-invasive ventilation

268

975

2.40

37.48

1.1

1.58

1.46

g/l

4.08

240

914

Dermatitis

741

4382

1.67

37.04

1.1

1.53

1.51

g/l

0.96

687

4012

Follow-up examination after treatment for conditions other than malignant neoplasms

468

1610

1.95

36.94

1.1

1.51

1.50

g/l

0.26

432

1482

Viral hepatitis

143

448

3.30

36.85

1.1

1.66

1.45

g/l

6.08

132

412

Biological medication for rheuma

277

1214

2.32

36.77

1.1

1.47

1.49

g/l

0.32

262

1117

Implicit fungal Sepsis, including avohilmo

117

322

3.74

36.77

1.1

1.51

1.48

g/l

0.23

106

293

Low back pain

911

3862

1.60

36.69

1.1

1.48

1.50

g/l

1.04

827

3564

Hypo-osmolality and hyponatraemia

216

839

2.59

36.56

1.1

1.66

1.54

g/l

2.81

194

751

Coagulation defects, purpura and other haemorrhagic conditions

267

1154

2.35

36.54

1.2

1.1

1.54

1.51

g/l

0.35

255

1050

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

708

4166

1.68

36.46

1.1

1.56

1.51

g/l

2.01

648

3813

Heart failure and coronary heart disease

451

1627

1.96

36.37

1.1

1.68

1.55

g/l

7.70

422

1458

Hypokalaemia

173

610

2.89

36.08

1.1

1.67

1.52

g/l

4.13

155

551

Acute bronchitis

484

2566

1.87

35.94

1.1

1.50

1.51

g/l

0.11

445

2340

Crohn's disease of large intestine

106

278

3.96

35.85

1.1

1.55

1.48

g/l

1.14

253

Anxiety (asthma-related co-morbidities)

744

3421

1.67

35.67

1.1

1.48

1.46

g/l

0.56

678

3173

Other diseases of intestine

210

824

2.59

35.52

1.1

1.56

1.52

g/l

0.75

195

740

Purpura and other haemorrhagic conditions

200

767

2.66

35.50

1.2

1.1

1.55

1.51

g/l

0.66

189

694

Hyperkalaemia

240

4.16

35.42

1.1

1.70

1.51

g/l

3.22

218

Malignant neoplasm, including Hilmo

1014

3810

1.56

35.39

1.1

1.55

1.48

g/l

4.89

949

3484

Malignant neoplasm, wide definition

1015

3817

1.56

35.20

1.1

1.55

1.48

g/l

4.98

952

3490

Gout, idiopatic and unspecified

297

1374

2.19

34.49

1.1

1.64

1.54

g/l

2.54

277

1246

Selective serotonin reuptake inhibitors

1108

3796

1.53

34.27

1.1

1.49

1.50

g/l

0.44

996

3502

Functional dyspepsia

321

1538

2.11

34.02

1.1

1.50

1.49

g/l

0.14

296

1402

Later onset COPD

276

983

2.28

33.92

1.0

1.1

1.60

1.58

g/l

0.33

247

886

Pain in limb

938

3830

1.57

33.90

1.1

1.51

g/l

0.15

851

3531

Gout, strict definition

230

964

2.43

33.81

1.1

1.68

1.55

g/l

3.73

214

875

Certain infectious and parasitic diseases, including avohilmo

773

2347

1.66

33.70

1.1

1.52

1.47

g/l

2.53

701

2145

Recurrent or chronic depression

500

1897

1.84

33.63

1.1

1.48

g/l

0.14

457

1749

Thrombocytopenia, unspecified

123

373

3.39

33.39

1.2

1.1

1.58

1.51

g/l

0.70

117

343

Factors influencing health status and contact with health services

316

713

2.24

33.26

1.1

1.49

g/l

0.03

288

654

Benzodiazepine use

1146

5227

1.49

33.12

1.1

1.54

1.50

g/l

2.92

1024

4825

Solid cancers, including Hilmo

985

3743

1.54

32.82

1.1

1.54

1.48

g/l

4.31

923

3421

Noninfectious colitis NAS

192

751

2.60

32.76

1.1

1.54

1.50

g/l

0.60

177

675

Alcohol dependence

339

1683

2.04

32.70

1.1

1.65

1.50

g/l

7.79

293

1555

Acute peritonitis

111

320

3.57

32.65

1.2

1.1

1.63

1.53

g/l

1.32

104

297

Polyneuropathies and other disorders of the peripheral nervous system

274

1256

2.21

32.63

1.1

1.57

1.53

g/l

0.70

250

1143

Other and unspecified polyneuropathies, also in other diseases

242

1055

2.33

32.54

1.1

1.55

1.53

g/l

0.20

222

962

Other and unspecified dermatitis

614

3668

1.69

32.40

1.1

1.53

1.51

g/l

0.68

570

3352

Asthma and allergy, excluding more controls

169

614

2.76

32.39

1.1

1.41

1.46

g/l

0.97

163

562

Erysipelas

613

3138

1.70

32.28

1.1

1.60

1.49

g/l

8.55

562

2846

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

652

3954

1.66

32.13

1.1

1.55

1.51

g/l

1.73

596

3617

Episodal and paroxysmal disorders

1214

4188

1.48

32.13

1.1

1.47

1.51

g/l

3.99

1106

3842

Other functional intestinal disorders

506

2598

1.78

32.08

1.1

1.52

1.51

g/l

0.36

466

2371

Other CVD (FINNGEN)

134

321

3.23

31.81

1.1

1.60

1.50

g/l

1.82

118

290

Certain disorders involving the immune mechanism

260

1180

2.24

31.80

1.1

1.52

1.51

g/l

0.21

250

1081

Fall on same level

1314

4860

1.45

31.72

1.1

1.52

1.49

g/l

2.03

1182

4498

Cholecystitis

168

625

2.73

31.65

1.1

1.60

1.51

g/l

1.38

157

568

Other metabolic disorders

187

735

2.59

31.61

1.2

1.1

1.17

1.49

g/l

12.07

165

673

Tumor necrosis factor alpha inhibitors

241

1063

2.31

31.60

1.1

1.45

1.48

g/l

0.79

226

977

Substance use, excluding alcohol

274

1276

2.18

31.40

1.1

1.56

1.46

g/l

2.93

246

1179

Chronic sinusitis

514

2949

1.76

31.35

1.1

1.45

1.51

g/l

3.93

472

2723

Finngen Rheumatological endpoints

1095

4182

1.49

31.33

1.1

1.50

1.49

g/l

0.57

999

3847

Acute sinusitis

641

3539

1.66

31.29

1.1

1.49

g/l

0.09

601

3250

Systemic connective tissue disorders

398

2132

1.89

30.68

1.1

1.56

1.51

g/l

1.50

369

1942

Non-ischemic cardiomyopathy

337

1334

2.02

30.65

1.1

1.62

1.51

g/l

5.00

314

1193

Other diseases of stomach and duodenum

271

3.71

30.64

1.1

1.57

1.52

g/l

0.59

249

Gout, unspecified

245

1102

2.26

30.60

1.1

1.65

1.54

g/l

2.69

227

1000

Asthma and allergy

169

634

2.67

30.43

1.1

1.41

1.47

g/l

1.33

163

583

Headache

720

3477

1.61

30.43

1.1

1.45

1.47

g/l

0.82

658

3182

Acute upper respiratory infections of multiple and unspecified sites

877

4176

1.54

30.39

1.1

1.50

g/l

0.17

804

3826

Pain, not elsewhere classified

331

1672

2.00

30.39

1.1

1.54

1.48

g/l

1.39

304

1520

Codes for special purposes

610

3668

1.66

30.35

1.1

1.54

1.50

g/l

1.83

558

3362

Provisional assignment of new diseases of uncertain etiology

609

3665

1.66

30.22

1.1

1.54

1.50

g/l

1.82

557

3359

ILD, hospital admissions 3, with pneumonia sepsis

120

381

3.22

30.20

1.1

1.67

1.54

g/l

1.78

104

349

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

106

314

3.45

29.84

1.0

1.1

1.68

1.55

g/l

2.13

100

283

Disorders of thyroid, IBD co-morbidities

197

535

2.55

29.78

1.1

1.48

1.46

g/l

0.15

183

498

Fungal Sepsis

209

4.12

29.76

1.1

1.51

1.49

g/l

0.11

192

ILD-related respiratory insufficiency

147

4.83

29.70

1.0

1.1

1.62

1.57

g/l

0.33

134

Malignant neoplasm

964

3750

1.51

29.63

1.1

1.55

1.48

g/l

4.53

904

3428

Diseases of peritoneum

144

513

2.87

29.61

1.2

1.1

1.61

1.52

g/l

1.18

133

470

Malignant neoplasm

961

3738

1.51

29.54

1.1

1.54

1.48

g/l

4.33

900

3418

All anxiety disorders

752

3715

1.58

29.51

1.1

1.48

1.47

g/l

0.26

685

3433

Dorsalgia

1097

3955

1.48

29.31

1.1

1.49

1.50

g/l

0.45

1003

3650

Mental and behavioural disorders due to tobacco

148

539

2.82

29.28

1.1

1.55

1.50

g/l

0.52

130

493

Smoking dependency

148

540

2.81

29.18

1.1

1.55

1.50

g/l

0.52

130

495

Implicit fungal Sepsis

196

4.19

28.93

1.1

1.50

1.49

g/l

0.05

181

Disorders of lipoprotein metabolism and other lipidaemias

897

3591

1.53

28.92

1.1

1.52

1.51

g/l

0.48

832

3282

Missing teeth due to accident, extraction or parodontitis

697

3934

1.59

28.90

1.1

1.57

1.53

g/l

2.25

624

3601

Other disorders of skin and subcutaneous tissue, not elsewhere classified

190

788

2.45

28.70

1.0

1.1

1.62

1.52

g/l

2.21

168

716

Falls/tendency to fall

1206

4195

1.45

28.69

1.1

1.50

1.49

g/l

0.24

1100

3888

Lower back pain or/and sciatica

1199

5211

1.44

28.68

1.1

1.49

1.51

g/l

0.92

1092

4793

Chronic laryngitis and laryngotracheitis

194

814

2.42

28.58

1.1

1.48

1.53

g/l

1.01

167

739

Any operation in hilmo

10.15

28.49

1.1

1.0

1.39

1.35

g/l

0.21

Symptoms and signs concerning food and fluid intake

145

528

2.79

28.45

1.1

1.52

1.49

g/l

0.45

134

469

Neurological diseases

943

3137

1.52

28.38

1.1

1.47

1.51

g/l

2.27

869

2884

Vocal cord dysfunction

148

473

2.79

28.37

1.1

1.48

1.44

g/l

0.62

135

437

Hypothyroidism, strict autoimmune

726

3022

1.58

28.05

1.1

1.48

1.50

g/l

0.69

657

2757

Pleural effusion

182

748

2.47

28.02

1.1

1.66

1.54

g/l

2.77

168

677

Intracranial trauma

651

2727

1.62

27.81

1.1

1.51

1.50

g/l

0.04

591

2517

Parasetamol

818

2673

1.56

27.59

1.1

1.50

1.48

g/l

0.81

761

2449

Soft tissue disorders

1117

3956

1.45

27.32

1.1

1.50

g/l

0.07

1023

3648

Other bacterial intestinal infections

218

980

2.25

27.32

1.1

1.64

1.51

g/l

3.72

201

884

Other reaction to severe stress, and adjustment disorders

444

2551

1.75

27.11

1.1

1.51

1.47

g/l

1.18

412

2354

Cerebrovascular diseases (FINNGEN)

322

1156

1.97

26.58

1.1

1.50

1.45

g/l

1.79

293

1057

Explicit bacterial Sepsis

142

532

2.72

26.52

1.2

1.1

1.64

1.48

g/l

3.70

133

476

Explicit bacterial Sepsis, including avohilmo

144

544

2.69

26.45

1.2

1.1

1.64

1.48

g/l

3.82

135

487

Solid cancers

923

3649

1.49

26.44

1.1

1.54

1.48

g/l

3.91

863

3334

Streptococcal septicaemia

127

450

2.88

26.42

1.2

1.1

1.64

1.51

g/l

2.24

118

406

Streptococcal septicaemia, including avohilmo

129

463

2.84

26.21

1.2

1.1

1.64

1.51

g/l

2.38

120

419

Bacterial intestinal infections, IBD co-morbidities

222

1025

2.20

26.08

1.1

1.64

1.52

g/l

3.53

204

931

Valvular heart disease excluding rheumatic fever

494

2079

1.71

26.04

1.1

1.57

1.51

g/l

3.04

449

1896

Heart failure and bmi 25plus

387

1412

1.85

25.99

1.1

1.67

1.53

g/l

7.38

364

1265

Other specific joint derangements/joint disorders

842

3496

1.51

25.90

1.1

1.49

g/l

0.08

758

3222

Any event in cancer register

1010

4066

1.46

25.86

1.1

1.55

1.48

g/l

4.69

944

3729

Diagnoses used for exclusion with ILD

287

1467

1.98

25.61

1.1

1.58

1.52

g/l

1.74

269

1333

Paralytic ileus and intestinal obstruction

274

1377

2.01

25.56

1.2

1.1

1.58

1.53

g/l

1.41

248

1245

Hypothyroidism, drug reimbursement

144

369

2.75

25.53

1.1

1.50

1.40

g/l

1.92

136

343

L04AC Interleukin inhibitors

118

411

2.95

25.46

1.1

1.51

1.46

g/l

0.75

111

376

Chronic rhinitis, nasopharyngitis and pharyngitis

392

2216

1.79

25.44

1.1

1.45

1.51

g/l

1.83

350

2039

Ischaemic heart disease, wide definition

826

3394

1.51

25.16

1.1

1.57

1.52

g/l

2.94

755

3095

Ulcer of lower limb, not elsewhere classified

176

750

2.38

25.08

1.1

1.66

1.54

g/l

2.95

160

682

Non-rheumatic valve diseases

487

2062

1.70

25.06

1.1

1.57

1.51

g/l

2.78

442

1881

Psychiatric diseases

1052

3667

1.44

24.85

1.1

1.52

1.49

g/l

1.15

962

3381

Obesity, other/unspecified

402

2306

1.76

24.84

1.1

1.50

1.48

g/l

0.48

366

2128

Other systemic involvement of connective tissue (FG)

291

1485

1.94

24.63

1.1

1.56

1.51

g/l

1.38

271

1348

Candidiasis, including avohilmo

356

1976

1.82

24.63

1.1

1.50

g/l

0.01

328

1804

Intestinal stricture

339

1855

1.85

24.56

1.2

1.1

1.57

1.53

g/l

1.27

310

1685

Diaphragmatic hernia

386

2196

1.77

24.55

1.1

1.53

g/l

0.04

352

2007

Other external causes of accidental injury

867

2919

1.50

24.48

1.1

1.49

1.50

g/l

0.02

795

2701

Abnormal weight loss

130

489

2.71

24.19

1.1

1.53

1.52

g/l

0.06

118

445

Use of hypnotics and sedatives

1167

4788

1.40

23.83

1.1

1.53

1.50

g/l

1.55

1059

4407

Other systemic involvement of connective tissue

302

1612

1.89

23.71

1.1

1.55

1.52

g/l

0.92

281

1460

Other bacterial intestinal infections, including avohilmo

271

1397

1.96

23.64

1.1

1.62

1.51

g/l

3.45

252

1258

Coronary atherosclerosis

654

2658

1.56

23.59

1.1

1.58

1.53

g/l

2.42

604

2409

Hernia of abdominal wall

508

3144

1.63

23.58

1.1

1.51

1.53

g/l

0.45

465

2878

Concussion

555

2697

1.60

23.40

1.1

1.49

1.51

g/l

0.39

508

2488

Nerve, nerve root and plexus disorders

1146

4967

1.39

22.91

1.1

1.51

g/l

0.05

1045

4554

Childhood asthma (age<16), excluding more controls

153

486

2.49

22.89

1.1

1.41

1.43

g/l

0.28

143

448

Adalimumab

152

635

2.44

22.78

1.1

1.45

1.47

g/l

0.30

141

579

Osteopathies and chondropathies

613

3640

1.55

22.73

1.1

1.56

1.51

g/l

2.54

554

3331

Osteoporosis

275

1323

1.93

22.58

1.1

1.60

1.54

g/l

1.16

245

1196

Combinations of oral blood glucose lowering drugs

295

1590

1.87

22.50

1.1

1.57

1.52

g/l

1.20

276

1452

Other disorders of urethra and urinary system

722

3359

1.50

22.36

1.1

1.52

1.51

g/l

0.41

663

3070

Childhood asthma (age<16)

153

493

2.45

22.23

1.1

1.41

1.44

g/l

0.41

143

455

Accidents

852

2919

1.47

22.14

1.1

1.50

g/l

0.14

780

2701

Non-allergic asthma

119

448

2.71

22.11

1.1

1.41

1.51

g/l

2.08

111

404

All influenza

289

1556

1.87

22.10

1.1

1.54

1.49

g/l

0.92

269

1415

Vascular disorders of the intestines

276

3.21

22.02

1.0

1.61

1.54

g/l

0.76

246

Weight loss

133

531

2.55

21.96

1.1

1.53

1.52

g/l

0.12

121

481

Other diseases of upper respiratory tract

1145

4317

1.39

21.93

1.1

1.48

1.52

g/l

3.22

1042

3970

Pure hypercholesterolaemia

771

3321

1.48

21.90

1.1

1.53

1.52

g/l

0.39

709

3029

Colectomy operation

194

912

2.16

21.89

1.1

1.54

g/l

0.02

187

821

Fibromyalgia

128

503

2.59

21.84

1.1

1.45

1.49

g/l

0.45

106

460

Other diseases of anus and rectum

310

1706

1.83

21.81

1.1

1.52

1.51

g/l

0.18

295

1551

Pulmonary heart disease, diseases of pulmonary circulation

326

1832

1.79

21.68

1.1

1.55

1.53

g/l

0.36

306

1661

Colorectal adenocarcinoma

210

1009

2.08

21.52

1.2

1.1

1.61

1.54

g/l

1.80

198

900

Other dorsopathies, not elsewhere classified

1064

3970

1.40

21.31

1.1

1.48

1.50

g/l

1.19

973

3662

Psoriasis vulgaris

234

1192

1.99

21.26

1.1

1.59

1.51

g/l

2.44

222

1092

Ulcerative rectosigmoiditis

122

476

2.62

21.19

1.1

1.51

1.48

g/l

0.28

113

431

Diseases of arteries, arterioles and capillaries

664

3245

1.51

21.16

1.1

1.62

1.53

g/l

5.12

603

2977

Mycoses

329

1871

1.78

21.08

1.1

1.54

1.51

g/l

0.61

300

1706

Chronic apical periodontitis

1186

4886

1.37

21.03

1.1

1.52

1.50

g/l

1.02

1065

4514

Myalgia

278

1513

1.86

20.62

1.1

1.47

1.50

g/l

0.65

244

1381

Colorectal cancer

242

1205

1.94

20.60

1.2

1.1

1.60

1.53

g/l

2.13

228

1080

Other or unspecified ileus, impaction or obstruction

192

921

2.11

20.52

1.2

1.1

1.59

1.53

g/l

1.16

176

824

Periodontitis

1075

4998

1.38

20.44

1.1

1.52

1.51

g/l

0.76

971

4598

Psoriasis

338

1960

1.74

20.26

1.1

1.58

1.50

g/l

3.54

318

1796

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

300

1662

1.80

20.07

1.1

1.54

1.46

g/l

2.84

273

1536

Papulosquamous disorders

441

2747

1.62

20.05

1.1

1.57

1.51

g/l

2.97

412

2508

Infections of the skin and subcutaneous tissue

661

4420

1.48

20.04

1.1

1.54

1.49

g/l

2.04

607

4069

Diseases of the musculoskeletal system and connective tissue

576

1859

1.56

20.00

1.1

1.48

g/l

0.09

526

1730

Suggestive for eosinophilic asthma

121

484

2.55

19.96

1.1

1.45

1.54

g/l

1.79

112

442

Symptoms and signs involving the skin and subcutaneous tissue

771

5094

1.44

19.90

1.1

1.51

g/l

0.07

714

4664

Calcific aortic valvular stenosis, operated

261

1354

1.87

19.81

1.1

1.63

1.57

g/l

1.57

238

1219

Calcific aortic valvular stenosis

261

1354

1.87

19.81

1.1

1.63

1.57

g/l

1.57

238

1219

Chronic viral hepatitis

322

2.94

19.80

1.1

1.67

1.43

g/l

5.49

296

Pacemaker

329

1764

1.75

19.78

1.1

1.66

1.55

g/l

4.30

311

1586

Chronic periodontitis, including avohilmo

1069

4999

1.37

19.77

1.1

1.52

1.51

g/l

0.67

964

4599

Other disorders of white blood cells

290

3.04

19.76

1.1

1.63

1.50

g/l

1.53

265

Injuries to the thorax

489

3128

1.57

19.75

1.1

1.58

1.52

g/l

2.33

444

2863

Malignant neoplasm of colon, including Hilmo

186

892

2.10

19.70

1.2

1.1

1.58

1.53

g/l

0.83

176

795

Benign neoplasm: Colon, unspecified

267

1457

1.85

19.68

1.2

1.1

1.56

1.54

g/l

0.30

234

1320

Thiazolidinediones

127

523

2.47

19.67

1.2

1.1

1.56

1.53

g/l

0.36

119

473

Spondylopathies

823

3407

1.43

19.64

1.1

1.53

1.52

g/l

0.38

745

3132

Viral pneumonia

156

705

2.24

19.49

1.1

1.53

1.51

g/l

0.22

146

647

Calcific aortic valvular stenosis, diagnosis (helper)

259

1351

1.86

19.33

1.1

1.62

1.57

g/l

1.40

236

1216

Operations 2 for CAVS

259

1351

1.86

19.33

1.1

1.62

1.57

g/l

1.40

236

1216

Paroxysmal tachycardia

221

936

1.98

19.33

1.1

1.60

1.45

g/l

4.52

202

853

Hernia

996

4822

1.38

19.27

1.1

1.51

1.50

g/l

0.20

903

4427

Disorders of lens

709

3014

1.47

19.15

1.1

1.56

1.52

g/l

1.79

642

2784

Dorsopathies

1075

3987

1.37

19.13

1.1

1.48

1.50

g/l

0.67

982

3679

Calcific aortic valvular stenosis, including rheumatic fever

259

1356

1.85

19.05

1.1

1.62

1.57

g/l

1.41

236

1221

Colorectal cancer, including Hilmo

262

1334

1.85

19.00

1.2

1.1

1.61

1.53

g/l

2.37

247

1200

Malignant neoplasm of colon

156

714

2.21

18.88

1.2

1.1

1.59

1.55

g/l

0.54

149

645

Genitourinary diseases

626

2088

1.51

18.78

1.1

1.51

1.49

g/l

0.54

584

1921

Benign neoplasm: Stomach

121

501

2.46

18.58

1.1

1.53

1.54

g/l

0.12

109

454

Other anxiety disorders

522

2910

1.54

18.57

1.1

1.47

g/l

0.01

477

2687

Duodenal ulcer

112

447

2.54

18.53

1.1

1.63

1.53

g/l

1.51

104

405

Other skin changes

222

1166

1.93

18.48

1.1

1.51

1.53

g/l

0.31

204

1051

Colon adenocarcinoma

130

557

2.36

18.43

1.2

1.1

1.59

1.55

g/l

0.54

124

500

Injuries to the head

1191

5313

1.33

18.41

1.1

1.52

1.50

g/l

1.40

1080

4895

Dysphagia

234

1254

1.88

18.26

1.1

1.52

1.51

g/l

0.24

213

1144

Hyperlipidaemia, other/unspecified

375

2057

1.65

18.23

1.1

1.54

g/l

0.04

345

1868

Haemorrhoids and perianal venous thrombosis

338

2003

1.69

18.19

1.1

1.51

1.52

g/l

0.18

316

1814

Benign neoplasm: Transverse colon

137

605

2.30

18.19

1.2

1.1

1.61

1.54

g/l

0.89

126

551

Agranulocytosis

140

625

2.28

18.10

1.1

1.61

1.51

g/l

2.02

131

568

Symptoms and signs involving the urinary system

788

4227

1.41

18.02

1.1

1.53

1.52

g/l

0.40

712

3883

Care involving dialysis

109

437

2.54

17.97

1.1

1.66

1.48

g/l

4.49

104

407

Syncope and collapse

429

2261

1.59

17.93

1.1

1.57

1.50

g/l

2.78

399

2046

Congenital malformations, deformations and chromosomal abnormalities

640

4192

1.45

17.78

1.1

1.49

1.48

g/l

0.38

600

3852

Volume depletion

107

428

2.54

17.66

1.1

1.79

1.53

g/l

5.65

381

Fissure and fistula of anal and rectal regions

258

1443

1.80

17.59

1.1

1.50

g/l

0.01

234

1311

Acute tubulo-interstitial nephritis

601

3462

1.47

17.51

1.1

1.61

1.49

g/l

7.44

556

3146

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

701

4501

1.43

17.39

1.1

1.49

1.48

g/l

0.41

656

4144

Angina pectoris

530

2326

1.52

17.32

1.1

1.55

1.53

g/l

0.56

489

2110

Enterocolitis due to Clostridium difficile

118

499

2.40

17.28

1.1

1.71

1.52

g/l

3.71

105

454

Disorders of calcium metabolism

302

2.84

17.19

1.1

1.70

1.50

g/l

3.18

268

Candidiasis

167

816

2.07

17.15

1.1

1.49

1.51

g/l

0.19

150

745

Ulcerative proctitis

337

2.73

17.07

1.1

1.50

1.48

g/l

0.28

306

Disorders of other endocrine glands

460

2956

1.54

17.05

1.1

1.51

1.49

g/l

0.47

425

2721

Other embolism and thrombosis

139

634

2.22

17.05

1.1

1.57

1.51

g/l

0.72

131

575

Sicca syndrome [Sjögren]

104

419

2.53

16.98

1.1

1.50

g/l

0.03

380

Sulfonylureas

271

1221

1.77

16.93

1.1

1.69

1.56

g/l

4.64

248

1096

Elevated blood glucose level

104

420

2.52

16.89

1.1

1.47

1.51

g/l

0.44

383

Disorders of porphyrin and bilirubin metabolism

6.11

16.87

1.1

1.45

1.42

g/l

0.15

External causes of morbidity and mortality

662

2285

1.46

16.77

1.1

1.50

1.49

g/l

0.27

609

2107

Sarcoidosis

160

779

2.08

16.64

1.1

1.53

1.51

g/l

0.38

155

710

Diseases of pulp and periapical tissues, including avohilmo

1053

4069

1.34

16.63

1.1

1.51

1.50

g/l

0.30

950

3762

Other complications of surgical and medical care, not elsewhere classified

121

527

2.33

16.62

1.2

1.1

1.52

1.49

g/l

0.44

114

482

Presence of cardiac and vascular implants and grafts

397

1837

1.60

16.55

1.1

1.61

1.55

g/l

2.51

364

1665

Other CVD

190

984

1.95

16.52

1.1

1.57

1.55

g/l

0.30

166

891

Bacterial pneumoniae

395

2197

1.59

16.47

1.1

1.57

1.50

g/l

2.30

377

1995

Other pleural conditions

113

481

2.38

16.35

1.1

1.72

1.53

g/l

3.25

104

438

Problems related to lifestyle

134

614

2.21

16.30

1.1

1.57

1.50

g/l

1.08

117

562

Other and unspecified disorders of skin and subcutaneous tissue

324

2.71

16.14

1.0

1.1

1.64

1.52

g/l

1.50

293

Psoriatic and enteropathic arthropathies

148

709

2.12

16.08

1.1

1.56

1.49

g/l

1.28

139

643

Alcohol-induced chronic pancreatitis

100

407

2.52

16.08

1.1

1.61

1.52

g/l

1.26

375

Special screening examination for infectious and parasitic diseases

255

1054

1.78

15.76

1.1

1.42

1.45

g/l

0.48

226

985

Umbilical hernia

299

1800

1.68

15.74

1.1

1.54

1.52

g/l

0.30

273

1661

Other joint disorders

921

3550

1.36

15.70

1.1

1.47

1.49

g/l

1.06

840

3273

Vitamin deficiency, wide

219

3.08

15.65

1.1

1.59

1.52

g/l

0.65

203

Vitamin deficiency

219

3.08

15.65

1.1

1.59

1.52

g/l

0.65

203

Bacterial pneumonia (organism specified)

419

2471

1.54

15.56

1.1

1.58

1.52

g/l

1.63

397

2238

Benign neoplasm: Ascending colon

155

765

2.05

15.56

1.1

1.51

1.55

g/l

0.57

145

695

Other symptoms and signs involving the circulatory and respiratory systems

303

2.72

15.39

1.1

1.54

1.50

g/l

0.33

273

Enlarged lymph nodes

166

843

1.99

15.34

1.1

1.52

1.49

g/l

0.51

151

764

Disorders of the thyroid gland

948

4610

1.34

15.32

1.1

1.48

1.52

g/l

2.15

870

4230

Injuries to the knee and lower leg

1232

5157

1.30

15.26

1.1

1.49

1.50

g/l

0.40

1112

4752

Vasomotor and allergic rhinitis

404

2570

1.55

15.24

1.1

1.41

1.50

g/l

5.10

365

2371

Atopic dermatitis, strict definition with reimbursement

335

2012

1.61

15.06

1.1

1.50

1.47

g/l

0.76

315

1863

Personality disorders, excluding more controls

272

1612

1.70

15.05

1.1

1.52

1.46

g/l

1.52

238

1493

Other intervertebral disc disorders

837

3677

1.36

14.97

1.1

1.49

1.51

g/l

0.63

761

3384

Fracture of rib(s), sternum and thoracic spine

312

1924

1.63

14.95

1.1

1.60

1.52

g/l

2.10

288

1753

Intestinal malabsorption

250

2.87

14.61

1.1

1.54

1.48

g/l

0.72

228

Diabetic maculopathy, excluding more controls

117

534

2.22

14.42

1.1

1.56

1.49

g/l

1.01

104

476

Senile cataract

612

2621

1.43

14.41

1.1

1.56

1.53

g/l

1.11

552

2417

354

2034

1.57

14.38

1.1

1.51

1.56

g/l

1.79

326

1830

Hypothyroidism, other/unspecified

875

4306

1.34

14.37

1.1

1.48

1.51

g/l

2.12

798

3948

Misadventures to patients during surgical and medical care

162

836

1.96

14.37

1.1

1.54

1.52

g/l

0.34

148

762

Other blood glucose lowering drugs, excl. Insulins

147

734

2.02

14.30

1.1

1.60

1.54

g/l

1.07

140

656

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

543

3663

1.44

14.28

1.1

1.47

1.53

g/l

2.98

485

3379

Polycystic ovarian syndrome, consortium definition

666

2732

1.40

14.23

1.1

1.49

1.48

g/l

0.34

606

2504

Other and unspecified rosacea

112

506

2.25

14.19

1.1

1.48

1.50

g/l

0.24

100

460

Cystitis

810

3563

1.36

14.16

1.1

1.52

1.51

g/l

0.43

749

3266

Actinic keratosis

320

1827

1.60

14.05

1.1

1.51

1.57

g/l

2.46

296

1640

Extracorporeal dialysis

348

2.53

14.04

1.1

1.66

1.52

g/l

2.35

326

Urinary track infection

555

1919

1.46

14.02

1.1

1.49

1.48

g/l

0.55

509

1758

Other arthritis (FG)

325

2057

1.59

14.02

1.1

1.53

1.50

g/l

0.79

306

1881

Colon adenocarcinoma, helper endpoint

130

626

2.10

13.99

1.2

1.1

1.59

1.56

g/l

0.32

124

562

Spondyloarthritis

183

991

1.86

13.98

1.1

1.52

1.50

g/l

0.26

165

903

Phobic anxiety disorders

159

823

1.95

13.87

1.1

1.52

1.46

g/l

0.93

143

759

Pruritus

131

635

2.09

13.86

1.1

1.48

1.51

g/l

0.36

121

583

Benign neoplasm: Caecum

123

583

2.14

13.83

1.1

1.54

g/l

0.05

109

526

Diseases of the eye and adnexa

847

3160

1.35

13.76

1.1

1.49

1.48

g/l

0.40

786

2937

Unspecified acute lower respiratory infection

170

905

1.90

13.74

1.1

1.57

1.51

g/l

1.05

155

827

Diseases of salivary glands

344

2218

1.56

13.71

1.1

1.49

1.51

g/l

0.54

314

2024

Anaemia in chronic diseases classified elsewhere

119

3.74

13.70

1.2

1.1

1.70

1.48

g/l

1.63

111

Bacterial pneumonia, not elsewhere classified

359

2042

1.55

13.69

1.1

1.55

1.50

g/l

1.52

342

1854

Other diseases of lip and oral mucosa

444

3021

1.48

13.69

1.1

1.51

1.50

g/l

0.30

412

2763

Chronic periodontitis, complicated

587

4092

1.41

13.69

1.1

1.58

1.52

g/l

3.10

532

3744

Other viral diseases, including avohilmo

417

2773

1.50

13.68

1.1

1.50

1.47

g/l

0.68

399

2561

Glomerular diseases

194

1080

1.82

13.61

1.1

1.59

1.51

g/l

1.87

177

992

Benign neoplasm: Sigmoid colon

194

1080

1.81

13.60

1.1

1.54

g/l

0.04

174

975

Benign neoplasm: Rectum, anus and anal canal

203

1146

1.79

13.57

1.1

1.56

1.54

g/l

0.22

183

1033

Benign neoplasm: Rectum

187

1031

1.83

13.54

1.1

1.55

1.54

g/l

0.14

168

930

Exposure to other specified factors

850

5522

1.33

13.53

1.1

1.49

1.50

g/l

0.49

776

5086

Other viral diseases

324

2060

1.58

13.51

1.1

1.50

1.48

g/l

0.39

310

1907

Menorrhagia

308

1057

1.63

13.43

1.1

1.48

1.51

g/l

0.65

274

949

Coeliac disease

134

665

2.04

13.32

1.1

1.48

1.49

g/l

0.15

120

609

Ovarian cyst

315

1119

1.62

13.32

1.1

1.47

1.51

g/l

0.84

294

1009

Ventral hernia

241

1438

1.69

13.22

1.1

1.49

1.53

g/l

0.82

222

1308

Other arrhythmias

639

3460

1.38

13.20

1.1

1.51

1.48

g/l

1.05

583

3164

DVT of lower extremities and pulmonary embolism

384

2546

1.51

13.15

1.1

1.53

g/l

0.00

357

2321

Skin changes due to chronic exposure to nonionizing radiation

327

1899

1.57

13.11

1.1

1.51

1.57

g/l

2.34

302

1703

Other/unspecified dorsalgia

376

2463

1.52

13.11

1.1

1.48

1.51

g/l

1.06

343

2262

Generalized anxiety disorder

180

989

1.83

13.11

1.1

1.44

1.46

g/l

0.37

167

915

Other specified/unspecified arthritis

284

1772

1.61

13.06

1.1

1.53

1.50

g/l

0.41

267

1621

Chronic ulcer of skin, not elsewhere classified

336

2.48

13.02

1.0

1.1

1.66

1.55

g/l

1.46

308

Conduction disorders

267

1305

1.65

12.95

1.1

1.58

1.51

g/l

1.75

244

1178

Arthropathies

925

3563

1.32

12.84

1.1

1.48

1.49

g/l

0.30

850

3286

Alzheimer disease, including avohilmo

1305

0.44

12.79

1.0

1.1

1.60

1.58

g/l

0.19

1159

Adjustment and management of implanted device

154

813

1.91

12.78

1.1

1.66

1.52

g/l

3.23

149

732

Hypotension

155

820

1.91

12.78

1.1

1.58

1.57

g/l

0.18

136

736

Convulsions, not elsewhere classified

228

1336

1.70

12.74

1.1

1.58

1.48

g/l

3.56

207

1220

Unspecific neurodegenerative disorder

116

1586

0.50

12.67

1.0

1.1

1.56

1.58

g/l

0.24

105

1421

Hypothyreosis and Thyroxine purchase for inclusion criteria

892

4471

1.31

12.61

1.1

1.48

1.51

g/l

2.04

814

4101

Other and unspecified effects of external causes

298

1900

1.58

12.53

1.1

1.47

1.49

g/l

0.41

284

1750

Gingivitis and periodontal diseases

985

3929

1.30

12.48

1.1

1.50

1.51

g/l

0.39

887

3616

Acute gastritis

325

2.47

12.44

1.1

1.61

1.50

g/l

1.50

298

Seborrhoeic keratosis

244

1485

1.66

12.44

1.1

1.48

1.53

g/l

1.22

231

1355

Intestinal adhesions without obstruction

399

2.31

12.42

1.1

1.59

1.50

g/l

1.21

355

Ethmoidectomy

150

794

1.91

12.42

1.1

1.50

1.51

g/l

0.12

137

724

Symptoms and signs involving cognition, perception, emotional state and behaviour

983

5106

1.29

12.40

1.1

1.51

g/l

0.12

873

4720

149

788

1.91

12.34

1.1

1.56

1.49

g/l

1.25

140

713

Statin medication

712

2969

1.36

12.33

1.1

1.49

g/l

0.05

661

2721

Cerebral cysts

340

2.43

12.26

1.1

1.56

1.49

g/l

0.74

312

Type 1 diabetes

244

1489

1.65

12.23

1.1

1.54

1.47

g/l

1.98

222

1361

Other disorders of veins

393

2630

1.48

12.16

1.1

1.53

1.50

g/l

0.68

352

2401

Idiopathic pulmonary fibrosis

335

2.42

12.14

1.1

1.62

1.56

g/l

0.71

306

Disorders of eyelid, lacrimal system and orbit

863

4857

1.31

12.12

1.1

1.49

1.51

g/l

1.15

782

4466

Venous thromboembolism

499

3416

1.41

12.10

1.1

1.53

g/l

0.08

466

3107

Inflammatory diseases of female pelvic organs

578

2859

1.39

12.08

1.1

1.48

1.49

g/l

0.27

536

2610

Unspecified urinary incontinence

431

2.23

11.98

1.1

1.53

g/l

0.05

391

Cutaneous abscess, furuncle and carbuncle

279

1772

1.59

11.96

1.1

1.57

1.49

g/l

2.07

255

1631

Other diseases of hard tissues of teeth

522

1909

1.42

11.87

1.1

1.52

g/l

0.02

471

1760

Sulfasalazine

257

1605

1.61

11.81

1.1

1.53

1.49

g/l

0.94

235

1446

Excessive, frequent and irregular menstruation

332

1145

1.56

11.79

1.1

1.47

1.51

g/l

0.91

297

1035

FESS (DNB20)

144

767

1.90

11.73

1.1

1.49

1.51

g/l

0.20

131

700

Other epidermal thickening

234

2.70

11.73

1.0

1.1

1.54

1.53

g/l

0.11

214

Disorders of skin appendages

516

3696

1.40

11.70

1.1

1.48

1.49

g/l

0.36

475

3396

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

223

1305

1.67

11.70

1.1

1.64

1.53

g/l

2.95

206

1177

Alcohol abuse, main dg, excluding more controls

162

896

1.83

11.69

1.1

1.64

1.49

g/l

3.76

144

827

Hypertensive heart and/or renal disease

226

988

1.68

11.66

1.1

1.62

1.55

g/l

1.66

206

886

Major coronary heart disease event excluding revascularizations

531

2512

1.40

11.60

1.1

1.62

1.53

g/l

4.36

481

2273

Injury, poisoning and certain other consequences of external causes

520

1846

1.42

11.56

1.1

1.50

1.48

g/l

0.53

474

1696

Single ventricle heart

24.17

11.55

1.4

1.0

1.53

1.25

g/l

—

Injuries to the ankle and foot

759

4945

1.32

11.50

1.1

1.47

1.49

g/l

0.79

703

4560

Mycoses, including avohilmo

938

5590

1.28

11.47

1.1

1.48

1.51

g/l

0.98

852

5140

Cellulitis

232

1425

1.64

11.46

1.1

1.57

1.50

g/l

1.91

216

1307

Other abnormal uterine and vaginal bleeding

209

885

1.71

11.41

1.0

1.1

1.45

1.53

g/l

2.18

188

794

Glomerular disorders in diseases classified elsewhere

130

676

1.95

11.40

1.1

1.59

1.52

g/l

1.23

121

619

Enthesopathies of lower limb, excluding foot

247

1543

1.61

11.39

1.1

1.50

1.51

g/l

0.05

229

1409

Persons encountering health services for specific procedures, not carried out

104

500

2.11

11.36

1.1

1.52

1.47

g/l

0.55

461

Liquid cancers

260

1554

1.59

11.32

1.1

1.60

1.52

g/l

2.06

246

1409

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

365

2.31

11.32

1.1

1.39

1.43

g/l

0.41

336

STROKE

508

2446

1.40

11.31

1.1

1.53

1.50

g/l

0.83

465

2223

Pollen allergy

212

1259

1.67

11.29

1.1

1.40

1.45

g/l

1.20

186

1168

Transport accidents

463

2733

1.42

11.20

1.1

1.48

1.49

g/l

0.29

426

2537

Bronchitis, not specified as acute or chronic

411

2.22

11.19

1.1

1.49

1.52

g/l

0.23

378

Intrahepatic Cholestasis of Pregnancy (ICP)

367

2.30

11.18

1.1

1.39

1.46

g/l

0.79

336

Other diseases of urinary system

954

4192

1.28

11.13

1.1

1.52

1.51

g/l

0.27

870

3856

Special screening examination for other diseases and disorders

116

584

2.00

11.11

1.1

1.51

1.52

g/l

0.18

107

534

Cardiomyopathy

160

895

1.80

11.10

1.1

1.70

1.50

g/l

6.74

152

811

Open wound of head

551

3803

1.37

10.96

1.1

1.57

1.51

g/l

3.08

494

3497

Other headache syndromes

405

2820

1.44

10.95

1.1

1.44

1.51

g/l

3.12

376

2583

Hyperkinetic disorders, excluding more controls

133

657

1.90

10.90

1.1

1.37

1.40

g/l

0.48

126

614

Rosacea

141

765

1.86

10.87

1.1

1.46

1.51

g/l

0.80

129

691

Peripheral artery disease

358

1920

1.48

10.87

1.1

1.69

1.55

g/l

7.48

322

1730

Exclusions for E4_PCOS_BROAD

189

1116

1.71

10.87

1.1

1.54

1.49

g/l

0.88

177

1021

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

300

1981

1.52

10.85

1.1

1.54

1.48

g/l

1.91

273

1826

Injuries to the abdomen, lower back, lumbar spine and pelvis

387

2648

1.45

10.82

1.1

1.54

1.51

g/l

0.66

349

2417

Acute alcohol intoxication, ICD10

218

1340

1.64

10.78

1.1

1.63

1.49

g/l

4.86

192

1235

Diseases of the ear and mastoid process

1171

4714

1.25

10.78

1.1

1.49

1.50

g/l

0.30

1075

4340

Other retinal disorders

598

3375

1.35

10.76

1.1

1.53

g/l

0.01

542

3067

Poisoning by drugs, medicaments and biological substances

251

1597

1.58

10.74

1.1

1.55

1.48

g/l

2.00

222

1468

Infections with a predominantly sexual mode of transmission

314

2094

1.51

10.71

1.1

1.48

1.47

g/l

0.27

278

1941

AV-block

148

694

1.83

10.66

1.1

1.63

1.52

g/l

2.08

138

621

Pulmonary embolism

260

1674

1.56

10.54

1.1

1.54

1.53

g/l

0.11

244

1517

Enteropathic arthropathies

121

3.32

10.50

1.2

1.1

1.55

1.43

g/l

1.35

113

Presence of other functional implants

524

2617

1.38

10.44

1.0

1.1

1.59

1.53

g/l

2.81

474

2370

N06DA Anticholinesterases

1349

0.48

10.35

1.1

1.55

1.58

g/l

0.31

1205

Use of anticholinesterases

1349

0.48

10.35

1.1

1.55

1.58

g/l

0.31

1205

Acute alcohol intoxication

248

1588

1.57

10.34

1.1

1.62

1.49

g/l

4.24

220

1464

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

439

2.12

10.29

1.1

1.39

1.48

g/l

1.18

397

Atopic dermatitis, strict definition

307

2014

1.50

10.27

1.1

1.49

1.47

g/l

0.60

289

1864

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

440

2.12

10.23

1.1

1.39

1.46

g/l

0.79

401

Hypothyroidism, strict autoimmune, 3 medication purchases required

790

4120

1.29

10.22

1.1

1.47

1.51

g/l

1.85

715

3779

Conjunctivitis (acute, non atopic), including avohilmo

1027

4960

1.25

10.18

1.1

1.48

1.50

g/l

1.18

928

4569

Colonic or urogenital fistula

271

1779

1.53

10.12

1.1

1.50

1.51

g/l

0.22

245

1632

Benign neoplasm: Duodenum

124

3.24

10.10

1.1

1.50

1.54

g/l

0.28

113

Pulmonary heart disease

260

1691

1.55

10.10

1.1

1.54

1.53

g/l

0.08

244

1531

Hypertensive Heart Disease

201

923

1.66

10.08

1.1

1.63

1.55

g/l

1.72

181

824

Benign neoplasm: Small intestine

206

2.68

10.08

1.1

1.47

1.55

g/l

0.77

189

Disorders of choroid and retina

775

4219

1.29

9.96

1.1

1.54

1.52

g/l

0.64

706

3852

Urticaria and erythema

363

2535

1.44

9.92

1.1

1.50

1.49

g/l

0.10

339

2321

Emotional disorders starting during childhood or adolecense, excluding more controls

178

2.76

9.91

1.2

1.1

1.43

1.41

g/l

0.14

162

Heartburn

107

548

1.97

9.85

1.1

1.44

1.48

g/l

0.67

499

Familial hypercholesterolemia

128

697

1.85

9.79

1.1

1.58

1.53

g/l

0.52

118

626

Atopic dermatitis

604

3637

1.33

9.76

1.1

1.48

1.47

g/l

0.42

561

3354

Gilbert syndrome

5.29

9.71

1.1

1.38

1.42

g/l

0.25

Infection due to other mycobacteria, including avohilmo

4.29

9.71

1.1

1.51

1.52

g/l

0.06

Pain and other conditions associated with female genital organs and menstrual cycle

192

977

1.65

9.62

1.1

1.43

1.50

g/l

1.72

181

887

Sciatica+with lumbago

510

3352

1.35

9.51

1.1

1.50

1.51

g/l

0.34

469

3091

Migraine

489

2799

1.36

9.49

1.1

1.41

1.49

g/l

4.41

461

2579

Poisoning by medicine

227

1455

1.57

9.49

1.1

1.55

1.48

g/l

1.65

201

1340

Lumbar disc prolapse

632

3573

1.31

9.47

1.1

1.48

1.51

g/l

0.93

576

3293

Shoulder lesions

724

3357

1.30

9.47

1.1

1.51

1.52

g/l

0.29

661

3086

Myocardial infarction

412

2055

1.41

9.45

1.1

1.67

1.54

g/l

6.62

372

1871

Idiopathic gout

488

2.01

9.45

1.1

1.67

1.56

g/l

1.30

440

Care involving use of rehabilitation procedures

610

4184

1.32

9.44

1.1

1.52

1.49

g/l

1.01

558

3831

Fracture of lumbar spine and pelvis

193

1188

1.63

9.43

1.1

1.63

1.53

g/l

1.94

175

1070

Malignant neoplasm of skin, including Hilmo

472

2308

1.37

9.39

1.1

1.51

g/l

0.06

438

2088

Amputation

482

2.01

9.38

1.1

1.69

1.55

g/l

2.21

436

Maternal care for other conditions predominantly related to pregnancy

200

1215

1.62

9.37

1.1

1.41

1.47

g/l

1.50

186

1126

Liquid cancers, including Hilmo

308

1854

1.47

9.33

1.1

1.59

1.51

g/l

2.51

290

1680

Diseases of oral cavity, salivary glands and jaws

506

1914

1.37

9.26

1.1

1.53

1.52

g/l

0.32

456

1764

Somatoform disorder

166

993

1.69

9.21

1.1

1.44

1.49

g/l

1.25

149

906

Disorders of adult personality and behaviour

291

1979

1.48

9.21

1.1

1.51

1.48

g/l

0.66

254

1838

Disorders of lacrimal system

423

3025

1.38

9.17

1.1

1.48

1.51

g/l

0.88

383

2762

Disorder of lipoprotein metabolism, unspecified

117

635

1.86

9.09

1.1

1.57

1.53

g/l

0.48

102

573

Infection due to other mycobacteria

4.43

8.93

1.1

1.51

1.54

g/l

0.14

Cardiomyopathies, Primary/intrinsic

115

627

1.85

8.82

1.1

1.70

1.50

g/l

5.34

110

571

Chronic diseases of tonsils and adenoids

774

3850

1.27

8.82

1.1

1.46

1.51

g/l

3.30

714

3555

Type 1 diabetes, wide definition, subgroup 1

194

1219

1.60

8.81

1.1

1.55

1.46

g/l

2.56

178

1112

Atherosclerosis, excluding cerebral and coronary sclerosis

319

1737

1.45

8.81

1.1

1.71

1.56

g/l

7.50

288

1568

KRA_PSY_EATING, excluding more controls

342

2.16

8.79

1.1

1.46

1.44

g/l

0.19

319

Cardiodefibrillation

298

2052

1.46

8.72

1.1

1.62

1.55

g/l

2.15

287

1845

Other malignant neoplasms of skin (=non-melanoma skin cancer)

391

1905

1.40

8.68

1.1

1.50

1.52

g/l

0.27

357

1718

Unspecified haematuria

377

2201

1.40

8.68

1.1

1.55

1.54

g/l

0.05

343

2001

Coxibs

236

797

1.56

8.63

1.1

1.51

1.55

g/l

0.78

214

742

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

271

1820

1.48

8.62

1.1

1.46

1.48

g/l

0.29

247

1690

Pneumonia derived septicemia

170

2.70

8.60

1.2

1.1

1.59

1.51

g/l

0.68

154

In situ neoplasms

346

2463

1.41

8.58

1.1

1.54

1.52

g/l

0.31

323

2248

Rheumatism, unspecified

132

757

1.76

8.58

1.1

1.45

1.52

g/l

1.35

123

687

Bipolar affective disorders

190

1198

1.60

8.57

1.1

1.47

1.48

g/l

0.18

174

1106

Disorders of oesophagus in diseases classified elsewhere

3.42

8.55

1.1

1.56

1.55

g/l

0.05

Fentanyl

422

2.03

8.55

1.1

1.71

1.52

g/l

2.65

379

Other cataract

400

2154

1.39

8.55

1.1

1.55

1.53

g/l

0.64

367

1978

Panic disorder

152

908

1.69

8.51

1.1

1.47

g/l

0.02

134

839

Lung diseases due to external agents

123

694

1.79

8.44

1.1

1.64

1.53

g/l

1.55

110

625

Acute suppurative otitis media

267

1691

1.48

8.43

1.1

1.47

1.45

g/l

0.19

256

1558

Crohn's disease (strict) with PSC

20.46

8.43

1.4

1.0

1.64

1.23

g/l

—

Peripheral arterial reconstruction

136

790

1.73

8.43

1.1

1.76

1.57

g/l

5.01

123

717

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

170

1015

1.64

8.43

1.1

1.52

1.49

g/l

0.69

165

927

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

175

1087

1.62

8.43

1.1

1.56

1.47

g/l

1.95

154

998

Any dementia

123

1468

0.58

8.40

1.1

1.61

1.57

g/l

0.38

113

1311

Acetic acid derivatives and related substances

231

770

1.56

8.37

1.1

1.51

1.55

g/l

0.69

208

716

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

408

2004

1.38

8.35

1.1

1.52

1.51

g/l

0.11

375

1806

Other disorders of lacrimal gland

349

2501

1.40

8.35

1.1

1.48

1.51

g/l

0.91

312

2284

Xerosis cutis

3.61

8.32

1.0

1.2

1.51

1.52

g/l

0.05

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

484

1.94

8.31

1.1

1.55

1.57

g/l

0.13

428

Spondylopathies (FG)

143

847

1.70

8.29

1.1

1.50

1.48

g/l

0.20

130

779

Suicide or other Intentional self-harm

247

1663

1.50

8.28

1.1

1.57

1.48

g/l

3.14

221

1529

Malignant neoplasm of skin

434

2165

1.36

8.23

1.1

1.50

1.51

g/l

0.28

398

1955

Disorders of parathyroid gland

172

1057

1.62

8.21

1.1

1.53

g/l

0.12

150

944

Intracranial injury

553

3963

1.30

8.18

1.1

1.52

1.51

g/l

0.24

494

3655

Vitamin B12 deficiency anaemia

445

1.97

8.13

1.1

1.51

1.54

g/l

0.25

400

Supplementary factors related to causes of morbidity and mortality classified elsewhere

308

2171

1.43

8.12

1.1

1.54

1.50

g/l

1.34

280

1988

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

179

1095

1.60

8.11

1.1

1.51

1.48

g/l

0.47

174

1002

Thyroiditis, ILD-related definition

109

601

1.83

8.11

1.1

1.47

1.49

g/l

0.28

551

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

495

1.92

8.09

1.2

1.1

1.49

1.50

g/l

0.17

453

All influenza (not pneumonia)

145

868

1.68

8.08

1.1

1.54

1.50

g/l

0.51

134

800

Symptoms and signs involving the nervous and musculoskeletal systems

539

4145

1.30

8.06

1.1

1.52

1.51

g/l

0.16

510

3788

Tobacco use

327

2.14

7.99

1.1

1.59

1.48

g/l

1.15

302

Allergic rhinitis

313

2191

1.42

7.97

1.1

1.40

1.47

g/l

3.15

280

2026

Drug-induced osteoporosis with pathological fracture

3.80

7.97

1.1

1.64

1.49

g/l

1.09

Spondylosis

506

3008

1.32

7.94

1.1

1.54

1.53

g/l

0.40

462

2769

Disorders of synovium and tendon

510

3300

1.32

7.93

1.1

1.46

1.51

g/l

2.25

460

3034

Symptoms and signs involving speech and voice

306

2164

1.42

7.93

1.1

1.52

1.51

g/l

0.04

278

1972

Personality disorders

272

1883

1.45

7.93

1.1

1.52

1.48

g/l

0.90

238

1746

Irregular menses

433

2418

1.35

7.91

1.1

1.48

1.47

g/l

0.32

401

2224

Other diseases of pericardium

232

2.37

7.91

1.1

1.61

1.49

g/l

1.07

213

Dental pulpitis, including avohilmo

940

4919

1.23

7.88

1.1

1.49

1.50

g/l

0.15

868

4527

Diseases of the myoneural junction and muscle

119

681

1.76

7.84

1.1

1.58

1.53

g/l

0.55

103

614

Alcohol withdrawal state with delirium

432

1.97

7.80

1.1

1.74

1.53

g/l

4.30

396

Cardiomyopathy (excluding other)

116

660

1.77

7.79

1.1

1.70

1.50

g/l

5.34

111

599

Other diseases of blood and blood-forming organs

384

2.03

7.78

1.1

1.52

g/l

0.02

346

Lung cancer and mesothelioma

132

656

1.72

7.75

1.1

1.63

1.55

g/l

1.28

118

587

Congenital malformations of the circulatory system

151

897

1.65

7.74

1.1

1.50

1.48

g/l

0.20

142

823

Nonorganic sleeping disorders, excluding more controls

195

1271

1.54

7.66

1.1

1.51

1.47

g/l

0.67

176

1180

Other female pelvic inflammatory diseases

141

851

1.67

7.65

1.1

1.50

g/l

0.00

130

773

DVT of lower extremities

153

943

1.63

7.63

1.1

1.52

1.51

g/l

0.14

141

857

Dementia

158

1711

0.63

7.62

1.1

1.60

1.58

g/l

0.25

141

1532

Adverse effects, not elsewhere classified

191

1242

1.55

7.59

1.1

1.46

1.49

g/l

0.51

184

1129

Basal cell carcinoma, including Hilmo

387

1924

1.37

7.57

1.1

1.52

g/l

0.02

355

1734

Urticaria

292

2068

1.42

7.53

1.1

1.50

1.49

g/l

0.16

270

1894

Superficial injury of head

222

1492

1.49

7.50

1.1

1.55

1.50

g/l

0.79

205

1360

Alcohol-induced acute pancreatitis

226

2.35

7.47

1.1

1.71

1.49

g/l

2.02

207

Personal history of other diseases and conditions

110

621

1.78

7.47

1.1

1.53

1.46

g/l

0.97

102

571

Viral and other specified intestinal infections, including avohilmo

270

1819

1.44

7.39

1.1

1.50

1.45

g/l

1.24

253

1672

Dental operations

536

2116

1.31

7.38

1.1

1.53

1.52

g/l

0.08

489

1939

Faecal incontinence

364

2.02

7.37

1.1

1.55

1.51

g/l

0.36

323

Non-selective monoamine reuptake inhibitors

321

2225

1.39

7.33

1.1

1.52

g/l

0.09

294

2042

Social phobias

505

1.86

7.31

1.0

1.1

1.52

1.44

g/l

1.14

468

Extreme obesity with alveolar hypoventilation

216

2.36

7.27

1.0

1.1

1.59

1.52

g/l

0.76

198

Caries of dentine, including avohilmo

708

2884

1.26

7.24

1.1

1.52

1.50

g/l

0.70

639

2661

Other and unspecified epidermal thickening

122

2.84

7.21

1.0

1.1

1.56

1.51

g/l

0.22

111

Osteomyelitis

361

2.02

7.20

1.1

1.63

1.51

g/l

1.27

329

Hyperparathyroidism

147

901

1.62

7.19

1.0

1.1

1.52

1.54

g/l

0.29

126

800

Sequelae with surgical and medical care as external cause

184

1203

1.54

7.17

1.1

1.59

1.53

g/l

1.24

177

1089

Disorders of muscles

100

559

1.81

7.17

1.1

1.48

g/l

0.00

509

Disturbance of activity and attention

135

800

1.66

7.16

1.1

1.37

1.43

g/l

1.50

128

737

Voice disturbances

249

1731

1.45

7.16

1.1

1.50

1.51

g/l

0.28

229

1580

Other enthesopathies

288

2056

1.41

7.12

1.1

1.46

1.51

g/l

1.68

264

1889

Other and unspecified drugs and medicaments

482

1.87

7.09

1.2

1.1

1.48

1.51

g/l

0.31

437

Pneumococcal septicemia

176

2.49

7.05

1.2

1.1

1.56

1.50

g/l

0.59

158

Dental caries, including avohilmo

651

2640

1.27

7.02

1.1

1.52

1.51

g/l

0.19

589

2430

Use of memantine

993

0.50

7.02

1.0

1.1

1.60

1.59

g/l

0.11

885

Use of other anti-dementia drugs

993

0.50

7.02

1.0

1.1

1.60

1.59

g/l

0.11

885

Viral infections characterized by skin and mucous membrane lesions

403

3039

1.33

7.01

1.1

1.50

g/l

0.06

380

2786

Caries of enamel

965

5239

1.21

7.00

1.1

1.45

1.51

g/l

5.69

876

4825

Fenamates

124

496

1.71

6.99

1.1

1.45

1.56

g/l

3.04

117

459

Sequelae of external causes of morbidity and mortality

232

1601

1.46

6.95

1.1

1.55

1.52

g/l

0.53

222

1443

Alcohol abuse, main dg

162

1038

1.57

6.94

1.1

1.64

1.51

g/l

3.05

144

954

Diseases of middle ear and mastoid

545

3488

1.28

6.94

1.1

1.49

1.48

g/l

0.20

510

3201

Degeneration of nervous system due to alcohol

125

2.79

6.94

1.1

1.65

1.56

g/l

0.69

114

Occupational exposure to risk-factors

190

2.42

6.92

1.0

1.1

1.43

1.54

g/l

1.01

175

Unspecified fall

474

3596

1.30

6.90

1.1

1.52

1.51

g/l

0.43

424

3309

Dementia, including avohilmo

181

1857

0.66

6.89

1.0

1.1

1.59

1.57

g/l

0.22

162

1663

Paracetamol or NSAID medication

146

446

1.66

6.89

1.1

1.48

1.49

g/l

0.01

134

421

Other extrapyramidal and movement disorders in other diseases

223

1530

1.47

6.89

1.1

1.48

1.52

g/l

0.98

205

1391

Adenocarcinoma and papilloma adenocarcinoma of rectum

451

1.88

6.87

1.2

1.1

1.65

1.55

g/l

1.07

402

Tubulo-interstitial nephritis, not specified as acute or chronic

293

2.10

6.85

1.1

1.63

1.51

g/l

1.01

269

Anti-inflammatory and antirheumatic products, non-steroids

245

842

1.47

6.84

1.1

1.51

1.54

g/l

0.42

223

784

Type 1 diabetes, wide definition

196

1311

1.50

6.84

1.1

1.55

1.47

g/l

2.07

180

1197

Mixed and other personality disorders

489

1.84

6.80

1.1

1.52

1.46

g/l

0.64

453

Other peripheral vascular diseases

425

1.90

6.78

1.1

1.52

1.51

g/l

0.11

392

Internal derangement of knee

358

2643

1.35

6.76

1.1

1.48

1.51

g/l

0.58

315

2423

Post-traumatic stress disorder

475

1.85

6.76

1.1

1.51

1.46

g/l

0.57

436

Other specified/unspecified bacterial intestinal infections

356

1.99

6.75

1.2

1.1

1.56

1.51

g/l

0.39

330

Other arthrosis

502

2610

1.29

6.74

1.1

1.50

1.52

g/l

0.35

450

2393

Carpal tunnel syndrome

572

3926

1.27

6.74

1.1

1.50

1.51

g/l

0.35

514

3590

Barrett oesophagus

243

2.21

6.72

1.1

1.54

1.53

g/l

0.05

223

Fracture of shoulder and upper arm

327

2406

1.36

6.70

1.1

1.60

1.50

g/l

3.71

293

2201

Injuries to the wrist and hand

988

5473

1.20

6.70

1.1

1.48

1.50

g/l

0.84

901

5038

Propionic acid derivatives

244

842

1.46

6.69

1.1

1.50

1.54

g/l

0.64

220

784

Emotional disorders starting during childhood or adolescence

222

2.26

6.66

1.2

1.1

1.43

1.44

g/l

0.05

202

Benign neoplasm: Descending colon

386

1.94

6.64

1.3

1.1

1.55

g/l

0.04

347

Other problems related to primary support group, including family circumstances

117

680

1.69

6.64

1.1

1.46

g/l

0.09

108

629

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

210

1246

1.48

6.64

1.1

1.41

1.43

g/l

0.50

195

1160

Other enthesopathy of foot (+metatarsalgia)

101

581

1.75

6.61

1.1

1.44

1.49

g/l

0.67

526

Infections with a predominantly sexual mode of transmission, including avohilmo

384

2653

1.33

6.59

1.1

1.46

g/l

0.05

340

2461

Metatarsalgia

530

1.79

6.59

1.1

1.44

1.49

g/l

0.71

481

Phlebitis and thrombophlebitis (not including DVT)

190

1275

1.50

6.58

1.1

1.53

1.51

g/l

0.38

179

1162

Rotator cuff syndrome

568

3093

1.27

6.58

1.1

1.53

g/l

0.01

527

2837

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

207

2.30

6.56

1.1

1.0

1.54

1.56

g/l

0.11

181

Degeneration of the brain due to alcohol

129

2.70

6.55

1.1

1.65

1.54

g/l

0.84

118

Migraine with aura

224

1553

1.45

6.55

1.1

1.39

1.49

g/l

4.65

214

1423

Other/unspecified enthesopathies of lower limb, excluding foot

417

1.89

6.50

1.1

1.47

1.49

g/l

0.16

383

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

474

1.83

6.49

1.2

1.1

1.65

1.55

g/l

1.17

425

Other and unspecified nerve root and plexus disorders, also in other diseases

203

1385

1.47

6.49

1.1

1.50

1.51

g/l

0.15

180

1267

Dizziness and giddiness

697

4402

1.23

6.49

1.1

1.49

1.51

g/l

0.91

625

4056

Peripheral artery operations in Hilmo

102

591

1.74

6.49

1.1

1.66

1.55

g/l

1.66

536

Varicose veins of other sites

376

1.94

6.46

1.1

1.63

1.48

g/l

1.29

343

Myocardial infarction, strict

361

1910

1.34

6.42

1.1

1.65

1.54

g/l

4.85

326

1736

Endometriosis

267

1099

1.42

6.40

1.1

1.47

1.51

g/l

1.03

250

990

Hyperkinetic disorders

139

854

1.60

6.40

1.1

1.37

1.43

g/l

1.61

132

790

Injuries to the shoulder and upper arm

828

5286

1.21

6.39

1.1

1.53

1.51

g/l

0.91

746

4863

Fracture of lower leg, including ankle

524

4072

1.27

6.34

1.1

1.53

1.51

g/l

0.54

489

3747

Aortic aneurysm

185

1220

1.49

6.33

1.1

1.58

1.55

g/l

0.41

170

1110

Benign neoplasm: Pancreas

143

2.57

6.33

1.1

1.58

1.53

g/l

0.27

130

Acquired haemolytic anaemia

103

2.87

6.30

1.2

1.1

1.60

1.55

g/l

0.32

Basal cell carcinoma

361

1844

1.34

6.29

1.1

1.52

g/l

0.01

329

1662

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

872

5656

1.20

6.27

1.1

1.48

1.50

g/l

0.82

816

5180

Superficial injury of thorax

142

905

1.58

6.27

1.1

1.54

1.50

g/l

0.55

125

826

Abscess of anal and rectal regions

480

1.81

6.26

1.1

1.46

1.48

g/l

0.11

435

Necrosis of pulp, including avohilmo

581

4607

1.25

6.26

1.1

1.50

1.49

g/l

0.11

532

4251

Suppurative and unspecified otitis media

340

2251

1.34

6.26

1.1

1.48

1.47

g/l

0.14

326

2072

Other and unspecified myopathies

466

1.82

6.24

1.1

1.62

1.54

g/l

0.83

420

Disorders of sclera, cornea, iris and ciliary body

517

4101

1.27

6.20

1.1

1.52

1.50

g/l

0.76

478

3764

Degenerative diseases of the nervous system

115

1336

0.62

6.17

1.0

1.1

1.60

1.58

g/l

0.20

104

1199

Other necrotizing vasculopathies

341

1.96

6.12

1.1

1.59

1.52

g/l

0.47

309

Right bundle-branch block

182

2.34

6.11

1.1

1.61

1.53

g/l

0.64

163

Retention of urine

278

1634

1.38

6.07

1.1

1.58

1.55

g/l

0.33

253

1486

Type of accident

271

1976

1.38

6.00

1.1

1.53

1.50

g/l

0.75

247

1803

Raynaud syndrome

509

1.77

6.00

1.1

1.48

1.49

g/l

0.08

463

Diseases of pulp and periapical tissues and dental caries

571

2333

1.26

5.96

1.1

1.53

1.51

g/l

0.61

517

2146

Disturbances of skin sensation

263

1912

1.38

5.94

1.1

1.43

1.49

g/l

2.23

240

1751

Other follicular disorders

445

1.82

5.93

1.0

1.1

1.54

1.48

g/l

0.66

411

Chronic tubulo-interstitial nephritis

160

2.41

5.90

1.0

1.1

1.65

1.49

g/l

1.28

146

Fracture of foot, except ankle

238

1704

1.40

5.90

1.1

1.48

1.49

g/l

0.26

218

1562

Malignant neoplasm of pancreas, including Hilmo

367

1.90

5.87

1.0

1.1

1.79

1.55

g/l

2.70

323

Viral pneumonia (unknown virus, not influenza)

382

1.88

5.85

1.1

1.57

1.49

g/l

0.63

352

L01XE Protein kinase inhibitors

285

2.03

5.84

1.1

1.60

1.53

g/l

0.78

262

Persistent mood disorders

171

1155

1.49

5.80

1.1

1.49

1.51

g/l

0.19

154

1048

Localized swelling, mass and lump of skin and subcutaneous tissue

290

2150

1.35

5.79

1.1

1.53

1.51

g/l

0.44

275

1952

Open wound of lower leg

140

908

1.55

5.76

1.1

1.53

1.52

g/l

0.05

123

831

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

194

1348

1.45

5.70

1.1

1.42

1.46

g/l

0.63

178

1250

Fall on and from stairs and steps

238

1715

1.39

5.69

1.1

1.54

1.51

g/l

0.46

219

1561

Superficial injury of lower leg

243

1758

1.39

5.67

1.1

1.49

1.51

g/l

0.31

222

1617

Malignant neoplasm of rectum

466

1.77

5.65

1.2

1.1

1.65

1.55

g/l

1.45

417

Behavioural syndromes associated with physiological disturbances and physical factors

905

5170

1.19

5.57

1.1

1.48

1.50

g/l

1.12

836

4744

Any dementia, excluding more controls

119

1277

0.64

5.55

1.1

1.59

1.57

g/l

0.29

109

1147

Disease of hard tissues of teeth, NOS

460

1888

1.28

5.55

1.1

1.53

1.52

g/l

0.12

420

1740

Abnormalities of gait and mobility

107

659

1.64

5.51

1.1

1.57

1.54

g/l

0.27

592

Medical abortion

513

2210

1.26

5.51

1.1

1.53

1.48

g/l

1.76

468

2010

Soft tissue disorders related to use, overuse and pressure

245

1785

1.38

5.50

1.1

1.49

1.52

g/l

0.66

224

1628

Persons with potential health hazards related to communicable diseases

355

2708

1.30

5.47

1.1

1.45

1.47

g/l

0.47

337

2505

Diabetic retinopathy, excluding more controls

287

1185

1.36

5.45

1.1

1.57

1.53

g/l

0.98

265

1076

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

307

2319

1.33

5.44

1.1

1.49

1.50

g/l

0.35

290

2113

Other predominantly sexually transmitted diseases, not elsewhere classified

162

1099

1.48

5.42

1.1

1.43

1.46

g/l

0.37

146

1013

Mixed connective tissue disease

3.08

5.42

1.1

1.53

1.47

g/l

0.46

Rheumatoid arthritis

274

1799

1.35

5.40

1.1

1.55

1.51

g/l

1.03

251

1639

Viral and other specified intestinal infections

188

1280

1.44

5.40

1.1

1.51

1.44

g/l

1.48

178

1174

Emotional disorders and disorders of social functioning with onset specific to childhood

253

2.03

5.40

1.2

1.1

1.43

g/l

0.02

232

Restless leg syndrome

127

821

1.56

5.34

1.1

1.50

1.51

g/l

0.13

120

748

Methotrexate

105

649

1.63

5.33

1.1

1.55

1.51

g/l

0.56

100

580

Spinal stenosis

421

2438

1.28

5.31

1.1

1.56

1.54

g/l

0.38

377

2237

Seborrhoeic dermatitis

589

1.66

5.30

1.1

1.48

1.53

g/l

0.66

539

Polyarthrosis

175

1089

1.45

5.25

1.1

1.60

1.52

g/l

1.46

156

985

Infectious mononucleosis, including avohilmo

501

1.71

5.20

1.1

1.46

1.45

g/l

0.03

461

Infectious mononucleosis

501

1.71

5.20

1.1

1.46

1.45

g/l

0.03

461

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

420

1.78

5.18

1.1

1.56

1.52

g/l

0.45

385

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

14.42

5.18

1.3

1.0

1.72

1.50

g/l

—

Other inflammation of eyelid, including avohilmo

419

3320

1.27

5.16

1.1

1.47

1.49

g/l

0.44

374

3067

Ankylosing spondylitis

525

1.69

5.16

1.1

1.52

1.49

g/l

0.39

479

Status post-ami

183

966

1.44

5.15

1.1

1.66

1.56

g/l

2.48

166

857

Thyrotoxicosis, other and/or unspecified

176

1226

1.44

5.15

1.1

1.49

1.51

g/l

0.18

164

1117

Other diseases of oesophagus

413

1.78

5.15

1.2

1.1

1.57

1.51

g/l

0.51

372

Valvular operations

111

703

1.59

5.11

1.1

1.62

1.50

g/l

1.78

106

639

Nasal polyp

171

1187

1.45

5.11

1.1

1.49

1.53

g/l

0.61

153

1092

Myocardial infarction, without ST-elevation

297

2030

1.32

5.10

1.1

1.66

1.56

g/l

3.25

266

1835

Presence of other devices

172

1175

1.45

5.10

1.1

1.49

1.53

g/l

0.73

161

1056

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

368

2837

1.28

5.10

1.1

1.47

g/l

0.09

342

2613

Amyloidosis, other/unspecified

3.14

5.10

1.1

1.79

1.53

g/l

1.67

Personal history of allergy to drugs, medicaments and biological substances

3.26

5.09

1.1

1.0

1.26

1.43

g/l

1.55

Degeneration of macula and posterior pole

366

2195

1.29

5.09

1.1

1.54

1.56

g/l

0.47

329

1982

Periapical abscess

447

3583

1.25

5.01

1.1

1.51

g/l

0.05

403

3296

Thoracic aortic aneurysm

127

834

1.53

5.01

1.0

1.1

1.56

1.54

g/l

0.27

117

765

Other necrotizing vasculopathies (FG)

281

1.94

4.98

1.1

1.62

1.51

g/l

0.62

258

Other shoulder lesions

531

1.67

4.95

1.1

1.53

1.48

g/l

0.54

479

Procreative management

334

2127

1.30

4.91

1.1

1.46

1.48

g/l

0.33

308

1965

Haemangioma and lymphangioma, any site

525

1.67

4.91

1.2

1.1

1.41

1.50

g/l

1.30

476

Other obstetric conditions, not elsewhere classified

263

1233

1.35

4.91

1.1

1.44

1.45

g/l

0.21

257

1142

Melanocytic naevi

285

2166

1.32

4.89

1.1

1.44

1.50

g/l

1.88

269

1981

Other maternal disorders predominantly related to pregnancy

482

2426

1.25

4.89

1.1

1.44

1.48

g/l

1.74

446

2221

Fibroblastic disorders

188

1339

1.41

4.88

1.1

1.53

g/l

0.04

173

1220

Acute pharyngitis

144

966

1.48

4.88

1.1

1.42

1.49

g/l

1.25

138

890

Left ventricular outflow tract obstruction (LVOTO), broad definition

106

673

1.59

4.88

1.1

1.58

1.49

g/l

1.41

623

Calculus of kidney and ureter

251

1879

1.34

4.79

1.1

1.48

1.53

g/l

0.97

231

1715

Keratitis

326

2533

1.29

4.76

1.1

1.52

1.49

g/l

0.41

298

2319

Injuries to the elbow and forearm

664

4763

1.20

4.75

1.1

1.52

1.49

g/l

1.28

598

4381

Seropositive rheumatoid arthritis

201

1447

1.39

4.75

1.1

1.57

1.51

g/l

1.62

180

1315

Congenital malformation of biliary tract

6.72

4.75

1.0

1.53

1.31

g/l

0.93

Fall on same level involving ice and snow

533

4376

1.22

4.75

1.1

1.50

1.51

g/l

0.07

483

4008

Insomnia

851

5049

1.17

4.75

1.1

1.47

1.50

g/l

1.10

787

4631

Disorder of bilirubin metabolism, other/unspecified

15.63

4.70

1.0

1.58

1.42

g/l

—

Herpesviral [herpes simplex] infections

108

695

1.57

4.70

1.1

1.51

1.49

g/l

0.13

101

633

Other viral diseases, not elsewhere classified, including avohilmo

253

1891

1.34

4.68

1.1

1.50

1.48

g/l

0.46

246

1750

Visual disturbances and blindness

458

3707

1.24

4.68

1.1

1.49

1.51

g/l

0.60

423

3385

Other melanin hyperpigmentation

2.62

4.67

1.0

1.1

1.44

1.55

g/l

0.89

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

253

1187

1.35

4.66

1.1

1.43

1.45

g/l

0.37

247

1097

Cystic kidney disease, including avohilmo

185

2.14

4.66

1.1

1.58

1.50

g/l

0.62

167

Speech therapy

217

1597

1.37

4.65

1.1

1.47

1.53

g/l

1.46

197

1456

Nonsuppurative otitis media

199

1250

1.39

4.62

1.1

1.50

1.47

g/l

0.37

185

1144

Infective dermatitis

103

659

1.57

4.60

1.1

1.56

1.53

g/l

0.37

603

Sleep disorders

862

5083

1.17

4.59

1.1

1.48

1.50

g/l

1.06

795

4663

Hypopituitarism

474

1.68

4.58

1.1

1.47

1.45

g/l

0.19

433

Use of pramipexole

176

1255

1.41

4.58

1.1

1.57

1.53

g/l

0.95

157

1130

Benign neoplasm of middle ear and respiratory system

414

1.73

4.57

1.1

1.51

1.53

g/l

0.12

381

Etanercept

385

1.76

4.55

1.1

1.41

1.49

g/l

1.19

353

Urolithiasis

268

2043

1.32

4.54

1.1

1.48

1.53

g/l

1.18

246

1869

Exclusions for E4_PCOS_CONSORTIUM

633

3295

1.20

4.53

1.1

1.49

1.48

g/l

0.37

578

3029

Other inflammation of eyelid

127

854

1.50

4.52

1.1

1.56

1.51

g/l

0.67

109

773

Glomerulonephritis

554

1.62

4.48

1.1

1.56

1.50

g/l

0.88

504

Disorders of tooth development and eruption

147

825

1.46

4.46

1.1

1.47

g/l

0.02

136

763

Superficial injury of abdomen, lower back and pelvis

138

946

1.47

4.46

1.1

1.43

1.50

g/l

1.42

127

860

Pre-eclampsia or eclampsia

180

1295

1.40

4.46

1.1

1.46

1.49

g/l

0.51

167

1180

Unstable angina pectoris

261

1555

1.32

4.43

1.1

1.56

1.55

g/l

0.19

242

1393

Sub-endpoint used in defining T1D endpoints

244

1812

1.33

4.42

1.1

1.55

1.49

g/l

1.59

222

1664

Specific personality disorders

216

1604

1.35

4.40

1.1

1.51

1.48

g/l

0.63

186

1485

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

557

1.61

4.39

1.1

1.60

1.52

g/l

0.82

505

Arthrosis

644

2952

1.20

4.38

1.1

1.51

g/l

0.03

582

2710

Thyrotoxicosis

213

1583

1.35

4.32

1.1

1.49

1.51

g/l

0.39

199

1432

Lichen simplex chronicus and prurigo

347

1.78

4.31

1.1

1.52

1.51

g/l

0.09

317

Emotionally unstable personality disorder

112

742

1.52

4.30

1.1

1.48

1.46

g/l

0.20

686

Viral warts

607

1.58

4.30

1.1

1.45

1.49

g/l

0.42

552

Assault

138

954

1.46

4.30

1.1

1.54

1.45

g/l

1.75

126

885

Leisure time condition

157

1111

1.42

4.30

1.1

1.52

1.51

g/l

0.11

140

1013

Pain in thoracic spine

138

955

1.45

4.27

1.1

1.49

1.52

g/l

0.40

127

876

Degenerative macular diseases

569

1.59

4.26

1.1

1.51

1.55

g/l

0.53

506

Polyuria

178

1290

1.39

4.24

1.1

1.51

1.53

g/l

0.30

161

1172

Vitreous haemorrhage

570

1.59

4.24

1.1

1.61

1.52

g/l

0.99

520

Other sleep disorders

642

1.55

4.20

1.1

1.51

1.52

g/l

0.16

587

Malignant neoplasm of rectum, including Hilmo

588

1.57

4.16

1.2

1.1

1.62

1.54

g/l

1.17

527

Cervical disc disorders

307

2413

1.28

4.15

1.1

1.52

g/l

0.01

286

2220

Migraine without aura

174

1261

1.39

4.15

1.1

1.38

1.47

g/l

3.32

164

1164

Pregnancy hypertension

337

2390

1.26

4.14

1.1

1.45

1.47

g/l

0.37

317

2193

Laparoscopic right hemicolectomy

286

1.84

4.12

1.1

1.54

1.55

g/l

0.06

258

Benign neoplasm: Adrenal gland

435

1.67

4.11

1.1

1.53

g/l

0.04

393

Eating disorder

449

1.66

4.11

1.1

1.46

1.45

g/l

0.14

416

Epilepsy

255

1954

1.31

4.10

1.1

1.53

1.51

g/l

0.29

234

1796

Olecranon bursitis

353

1.74

4.08

1.1

1.59

1.49

g/l

1.17

318

Malignant neoplasm of pancreas

287

1.83

4.06

1.0

1.1

1.83

1.54

g/l

2.56

249

Diseases of male genital organs

500

2071

1.22

4.06

1.1

1.48

1.52

g/l

0.99

460

1922

Varicose veins

475

2958

1.22

4.01

1.1

1.55

1.51

g/l

1.51

437

2694

Other infectious diseases, including avohilmo

470

1.63

3.97

1.2

1.1

1.63

1.52

g/l

1.45

434

Deviated nasal septum

294

2311

1.28

3.96

1.1

1.45

1.53

g/l

3.24

264

2130

Other and unspecified urticaria

171

1247

1.38

3.96

1.1

1.51

1.49

g/l

0.32

158

1132

Adhesive capsulitis of shoulder

140

987

1.43

3.95

1.1

1.49

1.52

g/l

0.58

134

898

Haemorrhage in early pregnancy

223

1644

1.32

3.94

1.1

1.45

1.49

g/l

0.85

206

1503

Open wound of forearm

573

1.56

3.93

1.1

1.62

1.50

g/l

1.59

519

Benign neoplasm of other and unspecified endocrine glands

114

774

1.48

3.93

1.1

1.51

1.52

g/l

0.07

107

700

Mental and behavioural disorders due to sedatives or hypnotics

419

1.66

3.89

1.1

1.61

1.45

g/l

2.51

382

Special screening examination for neoplasms

321

1.76

3.88

1.1

1.48

1.52

g/l

0.35

293

Rheumatoid arthritis, including avohilmo

307

2436

1.26

3.87

1.1

1.53

1.52

g/l

0.45

284

2223

Hyperhidrosis

132

2.22

3.87

1.0

1.1

1.44

1.49

g/l

0.16

117

Diabetic neuropathy

124

855

1.46

3.87

1.1

1.62

1.54

g/l

1.38

115

792

Demyelinating diseases of the central nervous system

497

1.60

3.86

1.1

1.49

g/l

0.01

455

Primary_lymphoid and hematopoietic malignant neoplasms

185

1372

1.35

3.86

1.1

1.61

1.54

g/l

1.45

176

1234

Ankylosing spondylitis, ICD10

545

1.57

3.84

1.1

1.53

1.48

g/l

0.66

501

Other symptoms and signs involving the nervous and musculoskeletal systems

363

2939

1.24

3.83

1.1

1.50

1.51

g/l

0.24

343

2684

Amyloidosis

2.57

3.82

1.0

1.1

1.78

1.54

g/l

1.66

Disorders of conjunctiva

775

5188

1.16

3.81

1.1

1.51

1.49

g/l

0.64

706

4766

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS